rfhg_58553.1

Basic information about the TSS

---

TSS ID: rfhg_58553.1 Species: human Chr: chr4		Start: 70839241 End: 70839275 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3586362,EH38E2302186)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK298883:0 GeneID: 2926 HGNC/MGI_ID: HGNC:4610 UniProt_ID: B7Z5F9 Nearer transcript ids and distances: AK294612:-41 ENST00000514161.5:-68 ENST00000508091.1:-98 AK094806:-197 ENST00000499044.6:-228 ENST00000502323.5:240 view more...

Gene_name: G-rich RNA sequence binding factor 1 Gene_symbol: GRSF1 Gene_synonyms: Gene_source: HGNC:4610

TATA-Box annotation

---

Distance to TSS:	245
Nearest PromoterID:	NM_001098477
Entrez ID:	2926
Nearest Unigene:	Hs.309763
Nearest Refseq:	NM_002092
Nearest Ensembl:	ENSG00000132463
Gene Name:	G-rich RNA sequence binding factor 1
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.058824
GC%:	0.514286
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GRSF1 p2@GRSF1 p4@GRSF1 p5@GRSF1 p6@GRSF1 p7@GRSF1 p8@GRSF1
Sample		p1@GRSF1	p2@GRSF1	p4@GRSF1	p5@GRSF1	p6@GRSF1	p7@GRSF1	p8@GRSF1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	82.79	1.17	0.58	0.19	0.39	7.79	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	76.88	0.00	0.00	0.40	0.00	7.28	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	77.55	0.96	0.19	0.58	0.00	7.52	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	80.88	0.21	0.00	0.00	0.21	6.65	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	85.26	0.22	0.00	0.00	0.00	8.77	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	70.16	0.19	0.00	0.39	0.00	7.36	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	118.75	1.09	0.00	0.22	0.65	10.24	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	80.17	0.48	0.24	0.48	0.24	6.06	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	99.81	0.43	0.00	0.21	0.00	8.98	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	91.00	0.58	0.58	0.00	0.00	6.38	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	89.74	0.00	0.00	0.00	0.40	6.87	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	94.32	0.00	0.41	0.41	0.81	9.35	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	183.76	1.29	0.00	0.81	0.16	10.64	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	132.61	1.35	0.00	0.30	0.15	10.67	4.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	171.03	0.88	0.22	0.44	0.00	13.17	4.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	162.46	0.75	0.00	1.51	0.00	9.56	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	160.75	1.97	0.22	0.00	0.44	10.05	5.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	168.30	0.42	0.00	0.42	0.42	8.01	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	151.42	0.00	0.00	0.53	0.53	9.06	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	150.14	1.05	0.45	0.15	0.15	7.97	4.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	138.86	1.07	0.00	0.27	0.27	9.22	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	128.09	1.90	0.00	0.17	0.17	8.63	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	135.59	1.03	0.26	0.52	0.13	9.05	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	181.52	0.24	0.49	0.49	0.00	11.41	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	185.75	0.52	0.00	0.26	0.00	11.87	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	172.50	2.22	0.32	0.32	0.63	8.55	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	166.49	1.65	0.55	0.55	0.00	4.95	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	151.35	2.12	0.24	0.24	0.71	10.61	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	128.25	1.13	0.16	0.32	0.00	9.05	4.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	158.89	1.99	0.00	0.90	0.18	7.96	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	150.73	1.26	0.21	0.00	0.42	10.26	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	156.11	1.17	0.59	0.20	0.20	9.96	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	118.60	1.06	0.63	0.21	0.00	8.02	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	89.89	1.98	0.49	0.49	0.16	6.10	3.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	154.45	1.12	0.00	0.56	0.19	8.60	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	156.94	0.96	0.38	0.19	0.38	13.41	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	149.40	1.43	0.00	0.61	0.61	8.38	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	148.09	2.22	0.20	0.40	0.20	7.05	5.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	168.81	1.62	1.08	0.00	0.00	12.15	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	126.03	1.20	0.24	0.48	0.24	10.32	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	140.92	1.18	0.00	0.00	0.24	6.35	5.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	94.13	1.02	0.00	0.59	0.29	4.25	3.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	153.53	0.63	0.63	0.42	0.00	8.22	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	151.40	1.40	0.52	0.17	0.00	7.87	4.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	160.02	1.20	0.00	0.80	0.20	10.64	6.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	131.68	1.86	0.00	0.23	0.00	8.84	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	170.09	0.72	0.48	0.24	0.00	7.44	3.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	143.06	0.89	0.00	0.30	0.30	8.64	4.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	166.36	0.96	0.00	0.24	0.00	8.14	4.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	128.40	1.42	0.20	0.00	0.00	6.47	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	128.51	1.23	0.20	0.00	0.20	7.17	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	175.23	1.78	0.00	0.44	0.00	9.78	3.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	237.87	27.98	13.99	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	137.68	1.77	0.00	0.35	0.35	8.16	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	132.89	0.99	0.00	0.00	0.00	8.28	5.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	68.79	4.19	0.00	0.84	0.00	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	73.94	2.30	0.00	0.00	0.00	3.21	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	178.58	0.65	0.32	0.00	0.00	7.78	4.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	196.56	1.93	0.00	0.32	0.00	8.03	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	114.42	1.89	0.31	0.94	0.31	5.03	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	158.64	2.12	0.71	0.00	0.00	9.87	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	132.91	1.68	0.00	0.00	0.00	9.53	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	95.54	3.18	0.00	0.00	0.00	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	94.80	1.70	0.34	0.00	0.34	4.08	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	199.50	0.65	0.00	0.32	0.00	14.95	5.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	175.36	1.42	0.35	0.00	0.35	11.71	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	173.74	23.69	0.00	0.00	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	133.09	1.46	0.00	0.00	0.00	8.29	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	140.33	0.00	0.00	0.00	0.00	10.41	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	145.43	0.00	0.00	0.00	0.00	7.51	6.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	134.13	0.99	0.00	0.00	0.00	8.28	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	167.97	1.55	0.62	0.00	0.00	12.99	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	141.56	1.53	0.00	0.00	0.00	10.40	4.59
Adipocyte - breast, donor1	11376-118A8	96.93	7.92	0.63	0.16	0.16	4.59	1.90
Adipocyte - breast, donor2	11327-117E4	77.17	4.01	0.32	0.32	0.16	5.61	1.93
Adipocyte - omental, donor1	11473-119C6	105.09	7.25	0.51	0.13	0.00	4.45	2.67
Adipocyte - omental, donor2	11474-119C7	70.26	3.74	0.00	0.00	0.00	5.23	2.24
Adipocyte - omental, donor3	11475-119C8	66.31	3.35	1.00	0.33	0.00	1.67	2.01
Adipocyte - perirenal, donor1	11476-119C9	91.87	6.38	0.00	0.64	0.00	3.83	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	32.99	0.00	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	50.58	0.90	0.00	0.00	0.00	1.35	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	41.71	2.26	0.35	0.00	0.00	2.78	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	74.90	1.56	0.39	0.20	0.00	5.08	1.96
Adipocyte differentiation, day04, donor2	13022-139D7	55.08	2.06	0.00	0.00	0.00	2.32	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	61.61	1.12	0.28	0.28	0.00	4.18	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	79.35	2.94	0.00	0.00	0.00	3.53	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	79.87	8.93	1.61	0.24	0.48	4.67	1.45
Adipocyte differentiation, day08, donor2	13023-139D8	56.80	2.58	0.00	0.00	0.00	2.58	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	46.39	2.67	1.07	0.53	0.00	1.60	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	80.13	1.11	0.00	0.00	0.00	4.45	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	62.38	9.15	1.25	0.00	0.00	1.66	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	45.71	4.02	0.25	0.00	0.00	2.01	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	63.81	4.58	1.31	0.65	0.00	2.95	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	51.76	3.65	1.22	0.00	0.00	2.44	2.13
Alveolar Epithelial Cells, donor1	11510-119G7	83.98	0.66	0.22	0.44	0.22	6.85	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	27.61	0.36	0.00	0.72	0.00	1.43	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	21.56	0.00	0.00	0.00	1.20	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	46.78	0.54	0.18	0.18	0.18	4.50	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	0.00	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	41.91	0.82	0.82	0.21	0.00	2.47	1.03
Anulus Pulposus Cell, donor1	11248-116E6	73.92	4.00	0.46	0.34	0.00	4.12	2.17
Anulus Pulposus Cell, donor2	11463-119B5	72.74	2.20	0.00	0.00	0.00	8.33	2.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	45.38	0.90	0.45	0.90	0.00	2.70	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	54.70	2.60	0.00	0.00	0.00	3.91	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	83.47	2.14	0.00	0.00	0.00	6.42	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.00	2.69	0.30	0.30	0.00	3.29	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	44.26	2.53	0.00	0.00	0.00	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	67.33	1.32	0.00	0.00	0.00	1.98	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	45.81	0.65	0.00	0.32	0.32	3.57	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	57.28	2.43	0.49	0.00	0.49	3.40	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	61.76	1.19	0.00	0.00	0.00	2.38	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	51.98	0.75	0.00	0.38	0.38	3.39	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	54.43	2.90	0.00	0.00	0.73	4.35	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	70.21	3.76	0.00	0.00	0.00	5.02	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	62.44	2.64	0.82	0.00	0.49	5.11	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	42.31	0.00	0.00	0.00	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	93.04	1.96	0.30	0.00	0.15	5.13	2.41
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	44.47	2.14	0.54	0.00	0.00	2.68	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	43.83	2.83	0.00	0.19	0.19	3.78	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	62.01	3.47	0.00	0.53	0.00	4.81	1.60
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	0.00	1.95	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	38.81	2.49	0.17	0.50	0.33	3.15	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	50.43	3.60	0.00	0.00	1.20	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	47.00	1.20	0.00	0.34	0.00	5.32	2.06
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	71.31	4.19	0.00	0.00	0.00	8.39	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	39.80	4.37	0.49	0.00	0.49	2.43	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.01	5.31	0.38	0.38	0.38	5.69	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	67.84	2.42	1.21	0.00	0.00	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	33.63	1.71	0.00	0.57	0.00	2.28	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	41.47	2.14	0.43	0.21	0.00	2.35	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	54.46	1.81	0.52	0.00	0.00	4.39	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	44.57	0.47	0.47	0.47	0.00	1.88	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	60.13	1.61	0.00	0.00	0.00	2.57	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	71.35	2.85	0.71	0.00	0.00	2.85	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	40.95	2.34	0.00	0.00	0.00	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.68	2.11	0.30	0.00	0.00	2.11	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	84.35	3.56	0.00	0.00	0.00	3.56	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	47.30	2.03	0.00	0.00	0.51	6.10	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	55.01	1.78	0.25	0.25	0.00	5.35	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	71.16	0.64	0.00	0.64	0.00	5.08	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	48.33	1.73	0.00	0.43	0.00	2.59	3.45
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	41.91	2.75	0.21	0.42	0.00	3.81	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	66.99	2.32	0.00	0.29	0.00	2.61	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	47.24	1.89	0.94	0.00	0.00	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	51.03	1.86	0.17	0.00	0.00	4.24	1.70
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	71.81	2.32	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	4.23	0.00	0.00	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	43.31	2.36	0.21	0.00	0.00	2.36	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	86.04	3.01	0.00	0.00	0.00	4.21	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	38.64	0.73	0.00	0.00	0.00	2.92	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	45.98	1.84	0.23	0.46	0.23	3.22	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	68.86	0.00	0.00	0.00	0.00	5.10	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	91.01	2.03	0.25	0.00	0.25	5.08	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	42.11	2.89	0.00	0.41	0.00	4.54	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	56.00	1.84	0.31	0.31	0.00	3.67	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	44.46	1.43	0.00	0.00	0.96	0.96	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	31.93	2.88	0.22	0.00	0.00	3.77	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	54.93	1.53	0.00	1.53	0.00	4.58	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	51.51	3.32	0.55	0.00	0.55	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	47.66	2.12	0.79	0.26	0.53	2.91	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	61.06	2.18	0.00	0.00	0.36	4.36	1.45
Astrocyte - cerebellum, donor1	11500-119F6	51.58	0.98	0.12	0.25	0.12	3.81	1.84
Astrocyte - cerebellum, donor2	11580-120F5	48.27	0.51	0.00	0.17	0.00	2.40	2.23
Astrocyte - cerebellum, donor3	11661-122F5	23.91	0.00	0.00	0.21	0.00	1.89	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	66.58	6.97	0.00	0.70	0.00	2.79	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	91.40	4.37	0.32	0.32	0.32	5.34	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	98.89	4.77	0.45	0.30	0.45	5.97	2.68
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	121.57	0.46	0.46	0.23	0.11	6.42	2.29
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	121.77	1.13	0.25	0.75	0.50	7.64	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	119.37	0.57	0.00	0.57	0.34	5.92	1.82
Basophils, donor1	12241-129G9	47.08	1.05	0.26	0.00	0.00	2.62	1.05
Basophils, donor2	12242-129H1	80.82	0.72	0.00	0.00	0.00	3.61	0.72
Basophils, donor3	12243-129H2	59.53	0.88	0.00	0.00	0.00	2.79	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	29.11	0.00	0.00	0.00	0.00	1.72	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	23.77	0.00	0.00	0.00	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	0.00	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	48.96	0.00	0.00	0.00	0.00	3.77	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	41.38	0.21	0.00	0.00	0.00	2.29	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	52.28	0.00	0.00	0.00	0.23	3.91	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	52.90	0.72	0.18	0.18	0.00	2.16	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	129.64	3.30	0.41	0.82	0.41	21.95	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	209.85	0.70	0.23	0.00	0.23	18.63	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	139.74	2.88	0.00	0.00	0.32	9.59	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	0.00	0.00	0.00	0.00	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	44.52	1.69	0.00	0.00	0.00	2.25	1.13
CD14+ Monocytes, donor2	11305-117B9	44.54	0.93	0.19	0.00	0.00	2.23	0.56
CD14+ Monocytes, donor3	11381-118B4	47.20	0.22	0.00	0.00	0.00	1.54	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	73.31	2.83	0.28	0.28	0.00	2.83	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	81.88	1.52	0.00	0.00	0.00	2.27	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	82.51	3.29	0.99	0.00	0.00	3.62	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	50.16	2.89	0.00	0.00	0.00	2.31	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	37.42	0.91	0.00	0.00	0.00	1.81	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	55.43	1.42	0.00	0.00	0.00	3.32	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	30.47	0.17	0.33	0.00	0.00	1.84	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.57	1.10	0.00	0.00	0.00	1.93	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	27.27	1.24	0.00	0.00	0.00	1.49	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	17.62	0.78	0.00	0.00	0.00	1.17	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	22.97	0.53	0.18	0.00	0.00	2.14	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.81	0.22	0.00	0.00	0.00	1.52	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	21.77	0.47	0.00	0.23	0.00	2.11	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	33.27	1.58	0.00	0.00	0.00	1.58	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	0.00	0.00	1.11	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	33.32	1.19	0.00	0.00	0.00	2.23	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.14	1.00	0.00	0.00	0.00	1.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	27.07	0.83	0.00	0.00	0.00	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.40	0.92	0.00	0.00	0.00	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.72	0.23	0.00	0.00	0.00	1.58	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.77	0.00	0.00	0.00	0.00	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	29.59	1.08	0.00	0.00	0.00	2.42	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	34.72	0.17	0.00	0.00	0.00	2.27	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	38.72	0.42	0.00	0.00	0.00	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.51	0.37	0.18	0.00	0.00	1.47	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.26	0.00	0.35	0.00	0.00	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.55	0.00	0.00	0.00	0.00	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.23	0.35	0.00	0.00	0.00	1.57	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	30.48	0.37	0.00	0.00	0.00	2.23	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.27	0.65	0.00	0.00	0.00	2.37	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	23.34	0.00	0.41	0.00	0.00	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	18.31	0.23	0.46	0.23	0.00	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.63	0.23	0.00	0.00	0.00	1.16	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	103.10	1.53	0.22	0.00	0.00	3.71	3.05
CD14+CD16+ Monocytes, donor2	11801-124D1	83.39	3.23	0.00	0.00	0.00	2.77	2.08
CD14+CD16+ Monocytes, donor3	11912-125G4	88.38	2.17	0.22	0.00	0.00	4.12	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	135.01	1.56	0.16	0.00	0.00	6.85	2.02
CD14+CD16- Monocytes, donor2	11799-124C8	111.95	4.72	0.17	0.00	0.00	5.24	1.92
CD14+CD16- Monocytes, donor3	11910-125G2	122.63	1.34	0.00	0.00	0.00	4.46	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	85.99	2.55	0.26	0.00	0.00	3.06	2.81
CD14-CD16+ Monocytes, donor2	11800-124C9	95.29	7.68	0.22	0.00	0.00	2.85	2.85
CD14-CD16+ Monocytes, donor3	11911-125G3	91.17	2.11	0.21	0.21	0.00	2.11	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	67.07	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	78.65	0.68	0.00	0.00	0.00	0.00	5.42
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	79.74	0.00	0.00	0.00	0.00	6.21	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	96.48	1.07	0.00	1.07	0.00	5.33	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	77.73	0.54	0.00	0.00	0.54	4.82	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	65.28	0.00	0.00	0.00	0.00	0.70	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	85.49	0.78	0.00	0.00	0.00	5.49	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	72.51	0.00	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	70.68	0.00	0.00	0.00	0.00	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	47.88	0.00	0.00	0.00	0.00	3.63	0.73
CD19+ B Cells, donor3	11705-123B4	43.92	0.00	0.00	0.00	0.00	1.51	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	72.73	0.40	0.81	0.00	0.40	3.23	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.91	1.60	0.40	0.40	0.00	2.80	2.40
CD34+ Progenitors, donor1	11545-120B6	60.24	3.01	0.00	0.00	0.00	6.02	0.00
CD34+ Progenitors, donor2	11625-122B5	38.20	2.81	0.00	0.00	0.00	4.49	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	122.87	1.50	0.00	0.38	0.38	10.52	3.01
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	124.47	2.48	0.00	0.68	0.23	9.70	2.48
CD4+ T Cells, donor1	11225-116C1	107.47	0.00	0.00	0.00	0.36	3.57	2.50
CD4+ T Cells, donor2	11306-117C1	109.61	0.00	0.00	0.00	0.00	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	95.46	0.91	0.00	0.30	0.30	4.27	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	138.08	0.26	0.00	0.26	0.26	4.85	2.81
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	178.33	1.35	0.00	0.45	0.22	7.86	2.47
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	152.64	0.57	0.00	0.57	0.29	11.79	3.45
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	141.28	0.00	0.00	0.00	0.00	5.22	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	139.76	1.40	0.00	0.00	0.00	4.21	7.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	181.29	0.00	0.00	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	101.45	0.87	0.29	0.14	0.00	3.90	1.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	136.08	0.34	0.17	0.17	0.17	3.90	3.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	110.43	0.32	0.00	0.00	0.16	2.90	3.39
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	115.21	0.45	0.00	0.00	0.00	3.59	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	124.03	0.70	0.35	0.00	0.00	8.04	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	99.88	0.00	0.00	0.00	0.00	3.08	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	108.78	0.84	0.00	0.00	0.00	4.22	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	132.35	1.66	0.00	0.21	0.00	6.86	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	143.01	0.33	0.00	0.33	0.00	6.68	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	157.45	0.00	0.00	0.00	0.27	7.07	2.72
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	154.35	0.54	0.00	0.00	0.00	5.90	4.29
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	123.73	0.00	0.00	0.00	1.79	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	125.35	0.74	0.00	0.37	0.00	7.23	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	114.16	1.73	0.22	0.22	0.43	4.55	2.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	125.67	0.42	0.00	0.00	0.00	5.88	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	123.37	0.00	0.00	0.00	1.01	3.03	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	113.51	1.30	0.00	0.00	0.00	4.77	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	108.52	0.87	0.00	0.44	0.00	4.79	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	145.49	0.49	0.49	0.00	0.00	5.94	5.44
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	120.94	0.00	0.00	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	125.62	1.40	1.40	0.00	0.00	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	125.73	0.55	0.28	0.00	0.00	5.82	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	145.27	0.98	0.00	0.00	0.00	6.13	3.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	163.24	1.54	0.00	0.00	1.54	6.16	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	127.13	1.07	0.00	0.72	0.00	5.37	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	121.88	2.77	0.00	2.77	0.00	4.15	4.15
CD8+ T Cells, donor1	11226-116C2	99.20	0.98	0.65	0.00	0.00	3.27	2.95
CD8+ T Cells, donor2	11307-117C2	73.21	0.00	0.00	0.00	0.00	0.38	1.88
CD8+ T Cells, donor3	11383-118B6	105.29	1.26	0.25	0.00	0.00	2.52	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	151.17	0.46	0.23	0.46	0.46	11.93	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	121.26	0.24	0.24	0.48	0.48	9.83	2.16
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	131.60	0.27	0.00	0.55	0.55	7.39	3.01
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	113.18	1.80	0.60	0.60	0.30	6.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	191.03	0.00	0.00	0.24	0.24	13.68	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	180.32	0.91	0.45	0.23	0.45	12.05	2.27
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	151.01	0.65	0.65	0.00	0.43	10.65	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	162.13	0.53	1.84	0.00	0.26	10.79	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	153.37	0.23	0.47	0.94	0.70	11.73	2.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	150.94	0.91	0.00	0.00	0.30	11.77	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	164.72	0.29	0.58	0.00	0.87	15.69	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	127.09	0.80	0.80	0.00	0.27	13.32	2.93
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	140.52	1.75	0.44	0.00	0.00	13.13	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	158.94	0.91	1.37	0.46	0.46	15.03	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	163.35	0.00	0.00	0.00	0.00	23.12	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	136.86	0.72	0.72	0.72	0.00	12.25	3.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	139.83	0.58	0.29	0.00	0.86	11.22	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	148.72	0.47	0.47	0.24	0.47	8.96	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	110.60	1.58	0.00	0.00	0.32	10.46	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	137.79	0.62	0.00	0.00	0.92	12.61	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	119.26	1.28	1.28	0.64	0.32	9.30	2.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	118.95	0.00	0.76	0.76	1.15	11.47	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	132.03	0.79	0.79	0.39	0.00	11.03	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	145.23	0.00	0.00	0.00	0.00	11.35	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	252.13	0.80	2.41	0.00	2.41	23.29	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	262.99	3.50	0.70	0.00	2.80	23.78	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	269.47	2.00	2.00	1.00	0.00	22.04	2.00
Cardiac Myocyte, donor1	11525-119I4	53.00	1.83	0.00	0.00	0.00	9.14	0.00
Cardiac Myocyte, donor2	11605-120I3	59.78	5.93	0.49	0.00	0.00	4.45	0.99
Cardiac Myocyte, donor3	11686-122I3	77.24	4.21	0.84	1.68	0.53	4.42	2.53
Chondrocyte - de diff, donor1	11261-116G1	91.87	1.04	0.00	0.00	0.35	4.16	2.08
Chondrocyte - de diff, donor2	11338-117F6	40.16	0.71	0.00	0.00	0.00	1.78	0.36
Chondrocyte - de diff, donor3	11410-118E6	57.80	2.05	0.23	0.11	0.23	5.01	2.62
Chondrocyte - re diff, donor2	11339-117F7	50.13	0.90	0.00	0.00	0.90	6.27	0.90
Chondrocyte - re diff, donor3	11411-118E7	58.64	1.62	0.81	1.21	1.21	0.81	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	94.33	5.62	0.46	0.23	0.00	4.02	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	92.77	1.71	0.43	0.21	0.00	6.41	2.78
Ciliary Epithelial Cells, donor3	11399-118D4	77.70	1.42	0.35	0.09	0.18	6.37	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	78.95	2.29	0.28	0.73	0.09	2.48	3.76
Corneal Epithelial Cells, donor1	11526-119I5	25.47	0.22	0.00	0.00	0.22	1.10	0.44
Corneal Epithelial Cells, donor2	11606-120I4	32.99	0.00	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	38.86	0.51	0.00	0.00	0.00	2.05	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	143.80	2.48	0.50	0.17	0.17	7.43	1.98
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	126.79	2.84	0.95	0.00	0.32	7.57	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	106.97	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	82.29	2.48	0.22	0.11	0.11	4.97	1.84
Dendritic Cells - plasmacytoid, donor1	11228-116C4	175.60	1.71	0.34	0.34	0.00	26.31	2.05
Dendritic Cells - plasmacytoid, donor2	11309-117C4	160.61	1.31	0.00	0.00	0.00	22.85	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	169.38	1.45	0.00	0.00	0.00	21.78	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	44.36	2.00	0.00	0.00	0.00	3.84	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	41.66	2.35	0.00	0.00	0.00	3.52	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	60.24	1.70	0.28	0.00	0.28	3.68	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	58.98	2.36	0.00	0.00	0.00	7.08	0.79
Endothelial Cells - Artery, donor1	11264-116G4	32.00	2.04	0.00	0.00	0.29	3.49	0.00
Endothelial Cells - Artery, donor2	11341-117F9	75.76	0.71	0.00	0.24	0.00	7.76	1.18
Endothelial Cells - Artery, donor3	11413-118E9	52.59	1.58	0.18	0.18	0.35	4.03	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	69.60	2.88	0.22	0.00	0.22	4.88	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	74.55	4.26	0.91	0.00	0.30	3.65	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	49.33	3.95	0.00	0.00	0.00	3.95	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	38.33	2.38	0.30	0.00	0.00	2.08	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	43.74	1.56	0.00	0.00	0.52	3.64	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	29.63	2.13	0.00	0.14	0.00	1.99	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	67.62	2.40	0.00	0.80	0.00	9.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	35.12	0.52	0.00	0.00	0.00	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.91	4.35	0.12	0.50	0.12	8.45	1.49
Endothelial Cells - Umbilical vein, donor2	11324-117E1	53.23	3.26	0.00	0.00	0.00	5.00	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	58.38	2.20	0.12	0.00	0.12	5.62	1.22
Endothelial Cells - Vein, donor1	11267-116G7	28.44	0.00	0.00	0.00	0.00	4.55	1.14
Endothelial Cells - Vein, donor2	11344-117G3	41.21	0.70	0.00	0.00	0.00	4.19	0.70
Endothelial Cells - Vein, donor3	11416-118F3	63.74	1.41	0.31	0.31	0.00	6.44	1.10
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	27.85	0.24	0.00	0.00	0.00	2.93	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	24.96	0.00	0.00	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	114.94	1.23	0.82	0.41	0.41	3.69	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	55.62	1.42	0.11	0.00	0.33	4.82	1.53
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	94.25	1.84	0.33	0.11	0.33	4.23	2.60
Fibroblast - Aortic Adventitial, donor1	11245-116E3	87.81	3.03	0.85	0.49	0.24	8.61	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.66	2.87	0.55	0.68	0.27	9.28	1.64
Fibroblast - Aortic Adventitial, donor2	11326-117E3	72.77	1.90	0.11	0.32	0.21	5.80	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	67.19	3.43	0.00	0.26	0.00	3.43	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	87.70	2.33	1.00	0.00	0.00	5.98	4.98
Fibroblast - Cardiac, donor1	11268-116G8	61.24	1.81	0.00	0.45	0.00	5.90	1.36
Fibroblast - Cardiac, donor2	11345-117G4	59.12	2.27	0.00	0.00	0.00	5.31	0.00
Fibroblast - Cardiac, donor3	11417-118F4	47.63	1.58	0.16	0.16	0.16	3.94	1.42
Fibroblast - Cardiac, donor4	11452-119A3	90.63	1.82	0.61	0.30	0.30	4.85	2.12
Fibroblast - Cardiac, donor5	11456-119A7	74.87	2.92	0.00	0.00	0.13	8.25	1.65
Fibroblast - Cardiac, donor6	11460-119B2	74.28	1.67	0.30	0.15	0.15	5.91	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.74	1.07	0.00	0.13	0.00	5.49	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	81.54	0.43	0.00	0.00	0.00	8.20	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	74.70	0.00	0.00	0.00	1.46	4.39	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	41.52	0.00	0.00	0.00	0.23	3.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	84.46	8.48	0.85	0.68	0.17	5.09	1.87
Fibroblast - Dermal, donor1	11269-116G9	78.89	0.00	0.23	0.23	0.00	7.98	2.35
Fibroblast - Dermal, donor2	11346-117G5	55.19	1.89	0.00	0.47	0.00	5.19	0.47
Fibroblast - Dermal, donor3	11418-118F5	88.13	1.33	0.36	0.24	0.12	6.89	1.93
Fibroblast - Dermal, donor4	11450-119A1	88.18	0.57	0.00	0.11	0.11	5.54	1.70
Fibroblast - Dermal, donor5	11454-119A5	99.79	1.05	0.35	0.52	0.35	8.02	1.92
Fibroblast - Dermal, donor6	11458-119A9	109.47	1.14	0.00	0.32	0.16	7.63	1.95
Fibroblast - Gingival, donor1	11237-116D4	85.37	1.67	0.42	0.21	0.21	5.00	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	120.00	5.50	0.52	0.00	0.52	6.29	4.45
Fibroblast - Gingival, donor2	11318-117D4	89.74	1.45	0.13	0.26	0.00	5.93	1.45
Fibroblast - Gingival, donor3	11394-118C8	67.78	1.64	0.48	0.00	0.29	4.83	2.03
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	54.02	1.04	0.00	1.04	0.00	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	62.38	0.53	0.00	0.18	0.18	3.35	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	94.78	2.81	0.47	0.47	0.16	5.92	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	82.49	1.76	0.81	0.14	0.41	6.76	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	128.10	1.06	0.00	0.00	0.35	6.70	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	106.90	1.90	0.29	0.15	0.29	6.43	2.92
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	89.45	3.14	0.00	0.41	0.00	6.00	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	121.32	1.86	0.33	0.11	0.00	7.68	2.30
Fibroblast - Gingival, donor9 (control)	11927-125I1	106.53	3.37	0.44	0.59	0.00	5.58	3.67
Fibroblast - Lung, donor1	11270-116H1	39.42	2.72	0.00	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	74.61	1.49	0.00	0.00	0.00	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	76.82	0.42	0.00	0.63	0.42	6.54	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	64.98	0.83	0.00	0.00	0.00	3.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	0.00	0.00	0.00	0.00	2.80	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	13.43	0.00	0.00	0.00	0.00	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	79.98	0.81	0.41	0.41	0.41	8.12	1.62
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	71.48	0.00	0.00	0.00	0.00	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	76.23	2.72	0.97	0.19	0.00	5.04	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	107.54	1.67	0.30	0.00	0.00	5.61	2.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	100.98	0.92	0.31	0.00	0.00	9.49	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	54.19	1.91	0.00	0.00	0.00	4.58	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	61.56	1.62	0.27	0.00	0.00	5.94	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	63.90	1.16	0.12	0.00	0.00	4.29	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	86.77	2.76	0.22	0.44	0.44	6.19	2.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	66.85	1.63	0.00	0.00	0.41	2.64	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.07	0.00	0.00	0.00	0.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	65.63	1.58	0.00	0.00	0.00	3.16	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	88.51	3.57	0.00	0.20	0.60	5.95	2.18
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	63.41	3.73	0.71	0.18	0.36	3.37	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	89.87	2.76	0.59	0.59	0.20	5.32	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	94.77	1.50	0.30	0.00	0.00	3.91	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	80.75	4.21	0.54	0.43	0.54	5.07	2.16
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	77.44	1.52	0.00	0.25	0.00	3.54	1.01
Fibroblast - skin normal, donor1	11553-120C5	72.85	1.97	0.66	0.16	0.16	3.94	1.80
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	117.10	2.61	0.00	0.60	0.40	4.81	3.01
Fibroblast - skin normal, donor2	11561-120D4	96.64	3.92	0.70	0.90	0.50	6.13	2.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	108.50	4.53	0.91	0.00	0.00	5.14	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	101.73	4.47	0.66	0.41	0.50	7.62	2.32
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	62.91	6.33	0.34	0.68	0.68	4.62	2.56
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	92.95	1.64	0.66	0.33	0.33	4.93	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	99.07	5.43	0.64	0.11	0.85	5.43	1.81
Fibroblast - skin walker warburg, donor1	11554-120C6	66.80	2.36	1.01	0.67	0.00	4.55	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	51.44	1.41	0.31	0.16	0.47	2.98	2.35
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	686.95	22.16	22.16	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	97.61	1.74	0.00	0.00	0.00	10.46	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	78.18	2.77	0.17	0.17	0.17	6.24	1.56
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	90.56	1.30	0.52	0.00	0.52	7.03	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	85.34	3.32	0.00	0.00	0.26	7.41	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	184.50	0.77	0.00	0.00	0.00	9.95	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	160.16	0.64	0.00	0.00	0.64	12.76	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	222.51	1.71	0.57	0.00	0.00	29.67	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	191.10	6.07	0.00	0.55	0.00	9.10	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	173.53	3.20	0.23	0.23	0.00	10.50	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	246.47	2.58	0.20	0.00	0.20	24.37	4.56
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	192.44	5.82	0.00	0.26	0.26	5.82	5.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	174.81	2.61	0.33	0.33	0.00	6.52	5.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	183.08	1.33	0.44	0.00	0.00	17.69	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	108.25	1.70	0.00	0.28	0.28	11.02	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	89.16	2.22	0.25	0.12	0.12	10.84	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	107.18	1.07	0.00	0.00	0.00	11.55	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	90.44	3.10	0.12	0.37	0.25	6.32	2.23
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	109.50	1.38	0.00	0.14	0.28	9.97	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	99.62	1.22	0.00	0.20	0.00	10.98	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	88.08	0.91	0.46	0.00	0.23	7.76	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	88.19	2.49	0.12	0.00	0.25	7.72	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	116.50	1.53	0.22	0.66	0.00	10.05	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	77.12	2.36	0.00	0.30	0.59	5.32	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	85.20	3.66	0.32	0.32	0.00	6.04	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	80.43	2.23	0.00	0.45	0.22	5.81	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	73.60	2.82	0.40	0.40	0.81	7.66	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	73.79	2.88	0.17	0.17	0.51	8.14	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	110.84	3.01	0.35	0.53	0.35	9.22	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	99.58	2.08	0.31	0.52	0.21	8.12	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	81.80	2.39	0.17	0.68	0.68	7.86	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	80.11	2.43	0.44	0.33	0.22	7.41	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	89.52	2.91	0.25	0.08	0.17	8.07	2.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	73.91	2.65	0.41	0.00	0.41	6.33	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	74.68	2.89	0.00	0.21	0.21	8.66	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	73.21	2.88	0.23	0.00	0.35	7.15	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	77.55	3.34	1.00	0.33	0.33	8.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	81.34	2.20	0.44	0.44	0.22	7.05	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	72.44	2.95	0.12	0.37	0.49	6.03	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	77.32	2.11	0.32	0.16	0.32	8.75	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	124.12	3.21	0.00	0.00	0.00	12.19	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	78.93	2.94	0.19	0.47	0.28	6.35	0.85
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	74.50	1.90	0.16	0.32	0.00	8.23	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	94.88	1.82	0.91	0.30	0.91	7.60	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	68.37	3.35	0.10	0.31	0.73	6.79	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	68.94	2.63	0.22	0.66	0.22	9.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	76.31	2.52	0.84	0.84	0.28	5.05	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	80.27	2.69	0.37	0.19	0.00	9.17	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	83.16	3.21	0.27	0.27	0.80	7.22	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	92.57	1.53	0.00	0.31	0.31	8.42	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	71.12	2.85	0.26	0.13	0.00	6.87	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	77.53	1.63	0.27	0.27	0.00	8.95	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	67.29	2.03	0.18	0.18	0.18	5.90	1.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	72.59	3.07	0.22	0.44	0.44	4.61	2.41
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	65.46	2.98	0.00	0.00	0.00	4.96	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	74.93	2.24	0.26	0.13	0.53	5.14	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	72.03	1.61	0.00	0.40	0.00	7.06	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	56.93	3.30	0.00	0.51	0.25	3.30	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	105.90	3.98	0.00	0.00	0.00	13.93	1.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	97.53	1.23	0.31	0.00	0.15	9.71	2.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	121.73	2.05	0.00	0.00	0.20	12.27	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	158.03	2.19	0.00	0.31	0.00	16.90	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	145.80	2.26	0.28	0.00	0.00	12.15	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	121.76	3.23	0.00	0.00	0.00	16.60	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	158.39	2.47	0.00	2.47	0.00	14.85	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	119.14	2.71	0.39	0.39	0.39	8.90	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	158.84	3.21	0.00	1.60	0.00	12.84	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	123.46	0.00	0.00	0.00	0.00	8.69	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	116.52	3.58	0.00	0.33	0.00	11.39	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	111.60	4.94	0.00	0.82	0.41	8.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	163.28	3.33	0.00	0.00	0.00	10.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	99.55	5.03	0.00	0.56	0.28	10.35	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	106.22	2.29	0.33	0.00	0.00	7.84	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	104.02	7.55	0.00	0.00	0.00	8.39	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	97.01	3.50	0.00	0.00	0.00	8.27	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	79.82	5.43	0.00	0.34	0.00	7.13	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	125.29	4.18	0.00	0.00	0.00	10.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	95.64	5.73	0.00	0.00	0.00	10.31	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	74.29	1.48	0.00	0.30	0.59	4.44	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	121.98	5.08	1.69	0.00	0.00	13.55	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	94.03	8.28	0.00	0.41	0.41	7.87	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	86.76	7.36	0.00	0.23	0.46	5.98	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	5.27	0.00	5.27	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	78.04	4.61	0.38	0.38	0.38	8.84	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	85.40	5.87	0.33	0.98	0.33	7.50	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	121.06	1.34	0.00	0.00	0.00	14.05	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	80.14	4.24	0.77	0.39	0.00	6.55	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	105.44	5.48	0.34	1.03	0.00	6.85	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	166.48	0.00	0.00	0.00	0.00	9.94	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	117.49	3.77	0.00	0.00	0.00	13.21	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	99.58	4.83	0.60	0.00	0.00	10.26	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	111.91	5.60	1.53	0.00	0.00	5.60	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	132.02	5.18	0.00	0.80	0.00	8.38	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	91.27	2.47	0.49	0.49	0.49	5.92	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	134.57	2.36	1.18	0.00	1.18	7.08	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	122.52	5.83	0.00	0.58	0.00	7.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	80.75	3.51	0.00	0.44	0.00	8.34	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	117.83	5.93	0.00	0.00	0.85	6.78	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	101.48	4.18	0.60	0.60	1.19	5.37	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	76.18	4.37	0.00	0.00	0.00	2.91	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	45.65	0.00	0.00	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	57.80	0.00	0.42	0.00	0.42	4.16	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	42.73	0.00	0.00	0.00	0.00	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	48.21	8.56	0.00	0.00	0.32	2.85	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	32.58	6.27	0.42	0.00	0.42	2.92	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	53.15	0.81	0.35	0.46	0.00	4.06	1.16
Hep-2 cells mock treated, biol_rep2	11899-125E9	57.90	1.01	0.17	0.34	0.17	3.38	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	58.01	0.68	0.23	0.00	0.23	5.46	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	56.51	0.87	0.11	0.33	0.00	4.70	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	52.01	1.29	0.21	0.43	0.43	4.94	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	52.10	1.08	0.00	0.00	0.22	5.38	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	50.81	0.87	0.12	0.62	0.00	5.73	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	46.32	1.37	0.17	0.17	0.00	4.46	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	41.01	0.64	0.32	0.32	0.00	2.24	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	50.37	1.12	0.00	0.00	0.00	2.24	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	32.03	0.00	0.00	0.00	0.00	3.90	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	74.03	2.64	0.00	0.00	0.00	5.29	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	39.86	0.71	0.00	0.00	0.00	3.17	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.80	1.45	0.00	0.00	0.00	3.63	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	54.03	2.45	0.17	0.52	0.00	5.25	0.52
Hepatocyte, donor1	11523-119I2	58.11	1.21	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	81.88	0.00	0.00	0.00	0.00	3.23	1.08
Hepatocyte, donor3	11684-122I1	57.67	0.00	0.00	0.00	0.00	0.00	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	143.59	0.65	0.00	1.31	0.65	16.32	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	56.45	2.10	0.17	0.17	0.35	4.19	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	51.86	2.20	0.55	0.41	0.41	4.25	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	54.13	0.00	0.00	0.00	0.00	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	62.30	1.38	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	0.00	0.00	0.00	0.00	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	79.59	0.00	0.00	0.00	0.00	11.37	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	51.69	0.00	1.67	0.00	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	0.00	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	66.17	0.00	0.00	0.00	0.00	3.97	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	42.13	0.00	0.00	0.00	1.11	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	0.00	0.00	0.00	0.00	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	52.28	0.00	0.00	0.00	0.00	2.52	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	52.59	0.00	0.00	0.00	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	58.79	0.00	0.00	0.00	0.00	5.81	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	57.96	0.00	0.00	0.00	1.61	6.44	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	50.52	2.44	0.00	0.00	0.00	3.26	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	42.40	0.00	1.26	0.00	0.00	2.10	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	75.55	1.61	0.80	0.00	0.00	7.23	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	39.70	0.00	0.00	0.00	1.85	5.54	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	38.71	0.47	0.00	0.00	0.00	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	37.19	0.00	0.00	0.00	0.00	4.53	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	0.00	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	64.57	0.00	0.00	0.00	0.00	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	57.17	1.27	0.00	0.00	1.27	5.08	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	45.91	0.64	0.00	0.00	0.00	5.10	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	0.00	0.00	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	44.99	0.00	0.00	0.00	0.00	3.57	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	69.68	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	40.74	0.62	0.31	0.00	0.00	2.47	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	42.14	0.00	0.00	0.00	0.00	7.02	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	66.01	0.00	0.00	0.00	0.00	6.29	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.11	0.00	0.00	0.00	0.00	4.87	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	42.05	0.00	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.01	0.00	0.00	0.00	0.00	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	0.00	0.00	0.00	0.00	6.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	0.00	0.00	0.00	0.00	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	0.00	0.00	0.00	0.00	8.31	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	0.00	0.00	0.00	0.00	8.55	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	63.51	0.00	0.00	0.00	0.00	6.44	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	0.00	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	27.49	0.00	0.00	0.00	1.06	4.23	1.06
Keratinocyte - epidermal, donor1	11272-116H3	80.05	1.22	0.41	0.16	0.41	5.47	1.22
Keratinocyte - epidermal, donor2	11349-117G8	36.90	0.59	0.00	0.00	0.00	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	74.68	0.19	0.00	0.00	0.00	3.98	1.61
Keratinocyte - oral, donor1	11251-116E9	94.56	2.72	0.23	0.23	0.11	4.54	2.72
Keratocytes, donor1	11527-119I6	44.35	0.34	0.00	0.00	0.00	2.41	0.69
Keratocytes, donor2	11607-120I5	37.50	0.00	0.00	0.00	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	84.18	0.20	0.00	0.20	0.20	3.56	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	70.33	0.00	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	49.62	0.00	0.00	0.00	0.00	4.31	1.08
Lens Epithelial Cells, donor2	11609-120I7	56.51	9.00	0.58	0.46	0.58	2.65	1.73
Lens Epithelial Cells, donor3	11690-122I7	97.48	3.03	0.40	0.20	0.50	7.77	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	47.08	2.85	0.47	0.12	0.24	4.86	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	40.47	2.23	0.00	0.00	0.28	3.63	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	56.20	2.83	0.31	0.00	0.00	4.09	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	39.25	2.15	0.00	0.00	0.00	2.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	38.14	0.00	0.32	0.32	0.32	5.36	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	32.88	2.26	0.11	0.11	0.11	3.02	0.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.70	2.05	0.00	0.00	0.00	4.10	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.30	0.76	0.00	0.00	0.00	2.28	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	33.08	1.83	0.00	0.00	0.00	2.67	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	42.32	2.77	0.40	0.00	0.00	3.16	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	40.13	1.55	0.39	0.19	0.00	4.85	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.26	1.48	0.19	0.00	0.00	2.04	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	42.51	1.39	0.35	0.00	0.00	3.83	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	35.30	1.19	0.24	0.00	0.00	5.49	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	33.92	2.06	0.14	0.00	0.14	2.75	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	46.19	4.00	0.00	0.00	0.00	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.30	0.31	0.00	0.31	0.00	3.12	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	38.98	0.73	0.00	0.00	0.00	3.11	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	37.19	1.65	0.66	0.00	0.00	5.92	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	28.70	0.59	0.00	0.29	0.00	4.10	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.64	0.75	0.00	0.00	0.00	2.99	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	37.34	1.94	0.48	0.00	0.00	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.85	1.62	0.00	0.00	0.00	3.23	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	37.24	1.51	0.30	0.00	0.00	3.78	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	27.99	1.04	0.52	0.52	0.52	3.11	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.53	1.26	0.00	0.42	0.21	4.19	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.68	1.65	0.15	0.00	0.00	2.41	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	54.34	0.69	0.00	0.00	0.00	2.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.76	1.32	0.19	0.00	0.38	4.52	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.11	1.06	0.00	0.21	0.00	1.80	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	44.10	2.91	0.00	0.00	0.00	4.36	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	38.04	0.66	0.00	0.00	0.33	4.30	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	30.11	1.49	0.00	0.00	0.00	2.23	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	50.72	1.11	0.00	0.00	0.00	4.44	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	41.26	1.24	0.25	0.25	0.00	5.19	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	26.81	0.96	0.14	0.00	0.00	3.02	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	45.99	2.57	0.00	0.32	0.00	3.22	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	58.43	1.22	0.00	0.30	0.30	3.96	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	44.51	2.94	0.14	0.14	0.14	3.92	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.47	3.20	0.71	1.07	0.00	4.27	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.66	0.48	0.00	0.00	0.00	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.87	1.56	0.47	0.00	0.16	1.56	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	46.55	2.86	0.72	0.72	0.36	5.73	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	40.18	0.65	0.00	0.00	0.00	3.59	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.07	2.35	0.00	0.00	0.00	3.53	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	49.01	1.61	0.37	0.50	0.12	4.08	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.97	0.51	0.00	0.51	0.26	2.56	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.45	0.30	0.00	0.00	0.00	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	72.51	0.00	0.00	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	64.44	1.53	0.00	0.00	0.77	7.67	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.96	2.23	0.00	0.00	0.74	2.97	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	78.70	1.69	0.00	0.00	0.00	8.04	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	66.11	2.11	0.00	0.00	0.00	7.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	58.84	0.93	0.93	0.00	0.93	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	60.80	1.03	0.52	0.00	0.52	3.09	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	49.96	1.19	0.00	1.19	0.00	3.57	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	67.41	2.26	0.23	0.23	0.45	5.20	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	82.89	2.04	0.00	0.29	0.29	2.91	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	72.03	1.35	0.45	0.00	0.00	3.15	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	86.30	1.76	0.68	0.41	0.41	6.23	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	88.33	2.05	0.51	0.51	0.00	6.68	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	59.28	2.12	0.00	0.35	0.00	5.29	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	63.97	0.67	0.00	0.00	0.67	6.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	98.82	1.53	0.00	0.51	0.51	5.60	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	77.64	1.07	0.80	0.00	0.00	5.87	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	72.93	1.70	0.38	0.19	0.00	3.40	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	96.33	1.23	0.61	0.61	0.00	3.68	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	80.73	2.45	0.00	1.63	0.00	7.34	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	68.72	2.08	0.42	1.04	0.42	3.12	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	94.17	1.40	0.00	0.28	0.28	5.89	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	66.97	2.06	0.00	0.00	0.00	7.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	72.58	1.74	0.00	0.00	0.29	4.06	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	91.17	1.79	0.00	0.00	0.30	4.78	2.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	66.39	1.66	0.00	0.00	0.00	3.87	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	79.89	1.41	0.35	0.00	0.00	5.30	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	91.09	2.58	0.37	0.37	0.00	5.16	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	57.56	0.00	1.15	0.00	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	76.75	1.54	0.00	0.77	0.00	3.84	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	79.26	1.13	0.57	0.57	0.00	6.23	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	55.79	2.46	0.00	0.00	0.00	5.74	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	67.78	2.71	0.00	0.45	0.45	4.07	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	91.20	1.44	2.87	0.00	0.00	7.18	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	77.68	1.49	0.75	0.00	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.86	0.00	0.37	0.00	0.00	8.18	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	91.32	0.86	0.43	0.86	0.00	5.60	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	60.80	2.57	0.00	0.86	0.86	5.14	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	70.63	1.67	0.00	0.00	0.00	4.33	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	97.74	0.60	0.00	0.00	1.21	3.62	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	54.04	0.71	0.00	0.00	0.71	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	58.78	0.00	0.00	0.00	0.34	4.81	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	76.22	0.54	0.00	0.54	1.07	5.37	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	72.05	0.67	0.67	0.00	0.00	4.04	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	74.45	2.22	0.37	0.37	0.37	6.30	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	3.49	0.00	0.00	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	59.23	0.00	0.00	0.00	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	68.83	1.20	0.00	1.20	0.40	5.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	95.22	0.73	0.73	1.45	0.00	8.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	70.52	3.07	0.00	0.00	0.00	6.13	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	85.83	0.49	0.00	0.00	0.49	5.43	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	76.22	1.88	0.00	0.00	0.94	3.76	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	66.37	2.01	0.00	0.00	1.01	6.03	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	71.20	1.80	0.00	0.45	0.00	6.76	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	72.29	1.72	0.00	0.00	0.00	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	75.71	0.89	0.00	0.00	0.89	3.12	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	79.38	1.17	0.00	0.39	0.00	4.69	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	89.06	0.66	0.00	0.00	0.66	2.64	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	67.98	2.08	0.00	0.52	0.00	3.11	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	86.20	1.31	0.44	0.44	0.00	3.06	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	82.19	1.12	0.00	1.12	0.56	4.47	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	76.85	1.77	0.44	0.44	0.44	6.62	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	87.94	0.77	0.39	0.00	0.77	4.24	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	91.65	1.01	0.00	0.00	0.00	5.57	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	77.86	0.96	0.00	1.44	0.96	5.77	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	85.47	1.19	0.40	0.40	0.80	6.36	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	89.32	0.61	0.00	0.00	0.00	7.29	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	67.79	1.38	0.69	0.00	0.69	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	69.92	1.14	0.00	0.00	0.38	5.32	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	88.82	1.55	0.52	0.00	0.00	5.16	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	72.56	1.21	0.00	1.21	0.00	4.84	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	78.91	0.63	1.27	0.32	0.32	3.49	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	106.62	1.07	0.00	0.00	0.00	3.20	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	75.28	1.15	0.57	1.15	1.15	6.32	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	85.88	1.54	1.03	0.00	0.00	6.17	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	89.13	1.41	0.00	0.00	0.00	4.24	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	68.67	0.00	0.57	0.00	0.57	5.11	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	77.38	0.83	0.00	0.00	1.25	3.74	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	94.75	0.78	0.78	0.00	1.57	7.05	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	73.49	1.25	0.42	0.42	0.84	5.43	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	78.52	0.46	0.00	0.93	0.46	3.72	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	92.33	0.00	0.00	1.34	2.68	4.01	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	81.27	1.60	0.00	0.00	0.00	5.35	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	95.37	0.81	0.00	0.40	1.21	4.45	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	103.71	0.92	0.00	0.00	0.92	7.34	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	79.13	0.89	0.89	0.00	0.89	7.11	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	83.20	1.14	1.14	0.57	0.00	6.27	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	99.70	0.00	0.77	1.53	0.00	5.37	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	92.47	0.55	0.00	0.55	0.55	3.28	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	82.41	0.00	0.00	0.89	0.00	6.24	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	95.14	0.26	0.52	0.26	0.52	7.80	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	79.57	0.66	0.66	0.00	0.66	3.32	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	87.30	0.00	2.08	0.00	2.08	16.63	2.08
Macrophage - monocyte derived, donor1	11232-116C8	58.35	2.73	0.00	0.00	0.00	3.87	3.19
Macrophage - monocyte derived, donor2	11313-117C8	62.39	1.47	0.37	0.18	0.00	3.67	1.65
Macrophage - monocyte derived, donor3	11389-118C3	68.56	1.57	0.39	0.13	0.00	2.62	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	68.50	2.12	0.00	0.53	0.00	5.31	1.06
Mallassez-derived cells, donor2	11929-125I3	52.61	3.96	0.32	0.48	0.32	3.64	0.32
Mallassez-derived cells, donor3	11930-125I4	59.90	2.50	0.69	0.28	0.00	5.00	0.83
Mammary Epithelial Cell, donor1	11273-116H4	119.47	1.40	0.50	0.40	0.50	10.26	2.69
Mammary Epithelial Cell, donor2	11350-117G9	87.15	0.58	0.29	0.00	0.58	8.11	1.16
Mammary Epithelial Cell, donor3	11422-118F9	42.15	0.25	0.00	0.00	0.00	5.24	0.50
Mast cell - stimulated, donor1	11487-119E2	31.19	1.36	0.68	0.00	0.00	1.36	0.68
Mast cell, donor1	11563-120D6	86.73	1.41	0.00	0.00	0.00	3.46	2.27
Mast cell, donor2	11565-120D8	74.59	2.38	0.30	0.00	0.00	2.38	1.78
Mast cell, donor3	11566-120D9	91.63	1.58	0.00	0.23	0.00	1.80	3.60
Mast cell, donor4	11567-120E1	71.80	1.60	0.18	0.00	0.00	2.13	2.84
Mast cell, expanded and stimulated, donor5	11940-126A5	106.90	0.67	0.22	0.11	0.67	3.44	3.33
Mast cell, expanded and stimulated, donor8	11942-126A7	161.10	2.33	0.00	0.00	0.00	1.75	2.92
Mast cell, expanded, donor5	11939-126A4	100.38	1.26	0.34	0.11	0.11	2.98	2.18
Mast cell, expanded, donor8	11941-126A6	132.39	2.34	0.50	0.00	0.00	4.85	3.18
Melanocyte - dark, donor1	11502-119F8	52.93	8.66	0.40	0.10	0.20	5.47	1.19
Melanocyte - dark, donor2	11582-120F7	53.64	6.92	0.35	0.35	0.35	6.58	1.04
Melanocyte - dark, donor3	11663-122F7	78.60	2.83	0.65	0.07	0.14	5.65	0.87
Melanocyte - light, donor1	11274-116H5	53.60	1.18	0.00	0.00	0.00	5.64	0.47
Melanocyte - light, donor2	11351-117H1	36.85	0.68	0.00	0.00	0.00	2.73	0.68
Melanocyte - light, donor3	11423-118G1	28.62	0.87	0.00	0.00	0.00	3.47	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	73.30	0.94	0.10	0.10	0.00	4.17	1.46
Melanocyte, donor2 (MC+2)	12739-135I3	61.59	2.15	0.27	0.27	0.00	4.03	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	64.55	1.87	0.54	0.00	0.00	7.23	0.27
Meningeal Cells, donor1	11493-119E8	74.81	0.87	0.00	0.37	0.25	6.82	1.24
Meningeal Cells, donor2	11573-120E7	62.50	1.76	0.00	0.44	0.44	3.52	2.20
Meningeal Cells, donor3	11654-122E7	103.51	1.39	0.00	0.16	0.08	6.85	2.12
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	89.54	2.57	0.57	0.00	0.00	5.70	2.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	81.51	2.52	0.40	0.50	0.70	6.54	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	21.03	0.00	0.00	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	76.78	0.72	0.00	0.00	0.00	5.74	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	62.47	1.91	0.21	0.42	0.21	4.24	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	79.92	1.01	0.00	0.50	0.00	5.53	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	56.92	0.44	0.00	0.00	0.00	4.40	1.32
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	46.76	0.00	0.00	0.00	0.00	4.38	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	45.01	1.02	0.00	0.00	0.00	2.25	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	57.62	2.08	0.42	1.11	0.97	4.02	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	21.93	1.49	0.00	0.00	0.00	1.49	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	83.15	3.82	0.66	0.39	0.66	4.08	2.11
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.44	0.89	0.00	0.30	0.00	2.37	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.00	0.00	0.00	0.00	0.00	3.20	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	88.97	1.42	0.00	0.00	0.00	6.03	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	52.85	5.94	0.63	0.63	0.31	4.69	3.13
Mesenchymal stem cells - umbilical, donor0	11214-116A8	62.41	1.45	0.00	0.00	0.73	6.53	0.00
Mesothelial Cells, donor1	11247-116E5	104.48	5.04	0.80	0.53	0.00	6.89	2.92
Mesothelial Cells, donor2	12156-128G5	52.55	3.50	0.50	0.00	0.50	7.51	1.50
Mesothelial Cells, donor3	11402-118D7	93.44	1.88	0.14	0.22	0.22	5.13	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	101.27	2.70	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	66.25	1.97	0.00	0.49	0.25	2.96	2.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	95.99	2.65	0.88	0.88	0.00	2.65	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	86.43	0.00	0.00	0.00	0.00	6.91	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	68.19	1.86	0.00	0.00	0.00	2.79	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	71.56	1.66	1.24	0.21	0.62	3.32	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	60.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	59.06	1.50	0.25	0.50	0.00	1.75	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	106.59	2.33	0.47	0.47	0.00	6.52	2.79
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.82	1.63	0.00	0.20	0.00	1.83	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	90.68	1.19	0.79	0.79	0.00	3.17	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	68.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	54.87	3.54	0.88	0.00	0.00	1.77	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	66.11	1.14	0.38	0.00	0.38	4.56	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	65.80	0.00	0.00	0.00	0.00	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	54.12	0.85	0.64	0.00	0.42	1.70	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	77.35	1.84	0.00	0.00	0.00	4.60	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	50.67	0.30	0.00	0.30	0.30	3.28	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	63.71	1.68	0.00	0.00	0.00	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	51.18	2.51	0.75	0.00	0.00	2.01	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	60.61	2.38	0.00	0.24	0.00	3.33	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	61.92	1.11	0.00	0.00	0.00	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	46.05	0.92	0.00	0.00	0.23	2.53	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	71.94	1.26	0.63	0.00	0.00	2.73	2.31
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	55.85	0.82	0.41	0.00	0.41	3.26	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	52.13	0.86	0.00	0.00	0.21	2.15	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	58.24	0.22	0.22	0.22	0.00	2.45	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	0.00	0.00	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	49.28	1.75	0.44	0.00	0.00	1.31	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	62.86	1.01	0.00	0.00	0.00	5.58	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	86.16	0.00	0.00	0.00	0.00	4.97	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	54.36	1.63	0.27	0.00	0.27	4.08	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	69.70	0.29	0.29	0.00	0.00	5.29	2.06
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	74.14	0.00	0.00	0.00	0.00	0.00	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	48.06	0.96	1.44	0.00	0.48	2.40	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	69.64	0.40	0.00	0.00	0.40	4.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	82.27	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	54.06	0.50	0.00	0.00	0.50	1.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	63.19	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	70.94	1.31	0.00	0.00	0.88	2.63	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	66.22	1.10	0.00	0.00	0.00	3.31	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	71.72	0.64	0.00	0.00	0.00	1.28	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	75.62	1.49	0.74	0.00	0.25	3.97	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	45.23	0.70	0.00	0.00	0.00	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	88.39	4.42	0.00	0.00	0.00	2.21	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	72.48	1.37	0.00	1.03	0.34	3.08	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	63.45	1.31	0.44	0.00	0.00	4.81	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	75.99	1.07	0.00	0.00	0.00	1.78	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	81.92	1.68	0.28	0.28	0.28	4.21	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	78.55	0.00	0.00	0.00	0.00	4.16	2.08
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	67.02	1.17	0.58	1.17	0.00	4.08	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	71.19	0.90	0.30	0.30	0.30	5.13	1.51
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	60.94	0.83	0.42	0.00	0.42	4.59	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	79.43	0.00	0.00	0.92	0.00	4.62	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	80.25	2.28	0.00	0.00	0.00	5.12	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	66.33	1.24	0.28	0.00	0.14	3.73	1.11
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	75.15	1.55	0.78	0.00	0.26	4.92	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	81.08	0.86	0.43	0.43	0.00	3.86	2.57
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	71.14	0.00	0.64	0.00	0.00	3.18	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	76.86	0.80	0.27	0.27	0.27	4.27	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	87.40	2.10	0.30	0.30	0.00	6.29	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	54.52	0.99	0.00	0.14	0.00	2.26	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	74.53	1.27	0.00	0.32	0.32	4.78	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	95.97	2.43	0.00	0.00	0.22	6.41	2.87
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	80.77	1.14	0.00	0.00	0.00	3.03	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	65.63	4.83	0.57	0.57	0.85	4.26	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	91.44	1.97	0.49	0.00	0.25	7.13	3.93
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	50.83	1.30	0.65	0.00	0.00	3.26	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	78.51	1.47	0.00	0.00	0.29	2.65	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	85.06	2.02	0.00	0.00	0.00	3.75	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	81.19	3.30	0.41	0.41	0.82	2.89	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	71.17	1.49	0.30	0.30	0.00	0.89	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	71.57	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	0.00	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	53.56	1.64	0.00	0.00	0.33	1.97	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	66.27	1.05	0.00	0.00	1.05	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	93.11	2.37	0.40	0.00	0.00	4.55	2.37
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	82.89	3.73	0.00	0.00	0.00	7.45	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	91.63	1.88	0.00	0.00	0.00	4.13	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	56.20	1.33	0.00	0.27	0.00	3.73	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	44.45	1.24	0.11	0.11	0.00	2.38	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	48.62	1.47	0.00	0.00	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	66.32	1.10	0.00	0.00	0.00	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	71.56	0.00	0.00	0.00	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	4.81	0.00	0.00	0.00	2.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	46.46	0.00	2.02	0.00	0.00	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	49.75	1.26	0.00	0.00	0.00	1.26	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	1.36	0.00	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	0.00	0.00	0.00	0.64	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	1.51	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	0.00	3.26	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	81.65	0.86	0.86	0.00	0.22	4.09	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	68.46	1.57	0.00	0.00	0.00	5.23	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	110.80	0.00	0.00	0.00	0.00	6.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	171.54	0.00	0.00	0.00	0.00	9.18	5.43
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	124.35	0.76	0.19	0.00	0.00	5.70	4.94
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	130.86	6.38	0.00	1.60	0.00	3.19	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	132.59	0.00	0.00	0.00	0.00	6.12	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	69.83	1.84	0.00	0.00	0.00	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	125.56	0.84	0.00	0.00	0.00	8.79	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	160.85	0.70	0.23	0.23	0.23	14.18	3.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	129.71	0.54	0.54	0.00	0.54	7.30	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	92.71	2.10	0.84	0.63	0.00	5.89	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	11.13	11.13	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	86.37	0.99	0.50	0.00	0.00	8.44	4.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	87.43	1.35	0.54	0.00	0.27	4.33	4.87
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	137.82	0.45	0.00	0.00	0.00	11.56	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	117.58	0.49	0.00	0.00	0.00	9.47	4.74
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	61.42	1.28	0.36	0.36	0.36	3.83	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	136.32	3.18	0.00	0.00	0.00	8.49	5.83
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	88.24	0.00	0.00	0.00	0.00	10.21	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	46.93	4.27	0.33	0.00	0.00	3.61	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	109.45	0.81	0.33	0.16	0.33	7.97	3.25
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	88.37	3.70	0.18	0.18	0.35	6.70	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	144.87	1.41	0.70	0.70	0.70	6.33	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	132.40	0.92	0.00	0.00	0.00	7.82	6.90
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	143.32	1.29	0.00	0.00	0.32	9.96	5.78
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	45.53	2.41	0.00	0.34	0.69	2.76	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	70.80	0.00	2.53	0.00	0.00	5.06	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	92.68	1.11	0.22	0.22	0.22	6.02	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	178.67	0.85	0.00	0.42	0.00	7.62	5.08
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	131.73	1.42	0.00	0.00	0.24	4.51	4.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	160.54	0.86	0.00	0.43	0.00	10.30	5.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	27.08	0.00	0.00	0.00	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	120.63	1.33	0.33	0.00	0.33	6.33	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	83.41	0.90	0.00	0.00	0.00	7.66	3.16
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	174.99	0.79	0.00	0.00	0.00	12.30	4.36
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	146.73	1.86	0.00	0.00	0.00	13.00	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	111.62	1.14	0.00	0.38	0.38	5.30	3.41
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	125.14	0.98	0.00	0.00	0.00	9.78	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	86.72	0.44	0.00	0.00	0.00	5.23	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	85.93	3.17	0.90	0.00	0.00	7.24	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	148.16	0.00	0.00	0.00	0.00	11.46	5.29
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	150.26	0.00	0.00	0.00	0.00	7.98	4.65
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	121.03	1.98	0.00	0.00	0.00	6.94	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	114.85	1.91	0.00	0.00	0.00	9.95	4.21
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	107.07	2.42	0.00	0.00	0.00	5.75	3.63
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	61.44	1.55	0.44	0.44	0.00	3.98	1.77
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	181.61	0.00	0.68	0.68	0.00	6.10	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	0.00	0.00	0.00	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	133.52	0.61	0.00	0.00	0.00	6.10	3.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	150.44	1.26	0.00	0.31	0.00	10.70	5.04
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	101.09	0.00	0.00	0.00	0.00	5.15	5.75
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	143.20	2.37	0.00	0.00	0.00	7.12	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	75.95	3.40	0.00	0.00	0.00	5.67	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	126.45	5.06	0.00	0.00	0.00	15.17	0.00
Myoblast, donor1	11241-116D8	83.36	2.11	0.50	0.62	0.12	7.70	1.24
Myoblast, donor2	11322-117D8	92.25	0.96	0.77	0.38	0.19	4.41	3.26
Myoblast, donor3	11398-118D3	97.03	1.85	0.67	0.50	0.84	8.41	1.68
NK T cell leukemia cell line:KHYG-1	10777-110G3	76.91	0.44	0.15	0.00	0.00	6.57	1.02
Natural Killer Cells, donor1	11230-116C6	83.95	0.92	0.00	0.00	0.00	3.08	1.23
Natural Killer Cells, donor2	11311-117C6	72.37	0.60	0.00	0.00	0.00	1.81	0.60
Natural Killer Cells, donor3	11387-118C1	78.04	0.92	0.00	0.00	0.18	2.39	0.55
Neural stem cells, donor1	11275-116H6	217.40	3.63	0.00	0.36	0.36	14.52	2.90
Neural stem cells, donor2	11352-117H2	102.06	1.93	0.00	0.00	0.00	9.63	3.85
Neurons, donor1	11494-119E9	79.65	5.69	1.14	1.14	0.00	4.55	1.14
Neurons, donor2	11574-120E8	57.02	1.54	0.22	0.00	0.00	6.16	2.86
Neurons, donor3	11655-122E8	116.75	4.11	0.82	0.82	0.00	3.29	7.40
Neutrophils, donor1	11233-116C9	21.34	1.86	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	28.10	0.00	0.00	0.00	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	75.40	1.78	0.12	0.12	0.24	3.92	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	66.10	1.95	0.00	0.00	0.00	7.81	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	76.41	2.41	0.20	0.00	0.20	5.01	1.60
Olfactory epithelial cells, donor1	11933-125I7	91.26	1.93	0.28	0.28	0.14	6.19	3.17
Olfactory epithelial cells, donor2	11934-125I8	99.73	2.75	0.29	0.14	0.43	7.67	2.32
Olfactory epithelial cells, donor3	11935-125I9	84.45	2.16	0.79	0.34	0.34	4.31	3.63
Olfactory epithelial cells, donor4	11936-126A1	105.19	2.92	0.19	0.29	0.29	6.62	3.21
Oligodendrocyte - precursors, donor1	11496-119F2	68.01	6.02	0.00	0.00	0.00	4.21	2.41
Osteoblast - differentiated, donor1	11276-116H7	48.49	0.64	0.00	0.43	0.21	4.68	1.49
Osteoblast - differentiated, donor2	11353-117H3	44.58	0.00	0.00	0.00	0.00	5.72	2.29
Osteoblast - differentiated, donor3	11425-118G3	42.21	0.62	0.00	0.00	0.00	1.86	1.86
Osteoblast, donor1	11277-116H8	34.01	1.17	0.20	0.00	0.00	4.69	0.98
Osteoblast, donor2	11354-117H4	93.41	1.40	0.00	0.00	1.40	5.62	2.11
Osteoblast, donor3	11426-118G4	96.86	0.53	0.53	0.53	0.18	7.46	2.49
Pancreatic stromal cells, donor1	11249-116E7	65.54	2.19	0.34	0.17	0.00	4.72	2.11
Pericytes, donor1	11491-119E6	19.69	0.45	0.00	0.11	0.11	1.11	0.22
Pericytes, donor2	11571-120E5	31.24	0.00	0.00	0.00	0.23	3.85	1.13
Pericytes, donor3	11652-122E5	60.83	0.81	0.00	0.81	0.41	3.66	0.81
Perineurial Cells, donor1	11499-119F5	71.88	2.37	0.68	0.57	0.23	5.76	1.36
Perineurial Cells, donor2	11579-120F4	71.03	8.74	0.55	0.55	0.83	7.27	1.93
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	104.87	1.27	0.32	0.00	0.00	3.51	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	68.07	0.98	0.00	0.00	0.00	3.43	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	71.05	0.26	0.00	0.13	0.00	3.36	1.16
Placental Epithelial Cells, donor1	11278-116H9	49.99	0.48	0.00	0.24	0.00	3.11	3.11
Placental Epithelial Cells, donor2	11355-117H5	47.68	2.22	0.00	1.11	0.00	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	32.98	1.18	0.00	0.00	0.00	1.77	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	66.45	0.63	0.32	0.00	0.00	6.65	1.90
Preadipocyte - breast, donor1	11467-119B9	97.55	6.38	0.38	0.75	0.00	5.44	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	83.02	4.31	0.39	0.13	0.13	6.27	1.70
Preadipocyte - breast, donor2	11328-117E5	79.25	2.48	0.00	0.45	0.00	2.70	2.25
Preadipocyte - omental, donor1	11468-119C1	103.26	5.11	0.96	0.43	0.53	5.33	2.77
Preadipocyte - omental, donor2	11329-117E6	97.77	4.36	0.44	0.00	0.87	6.11	1.31
Preadipocyte - omental, donor3	11403-118D8	99.99	4.15	0.29	0.57	0.14	6.73	1.58
Preadipocyte - perirenal, donor1	11469-119C2	56.10	5.91	0.98	0.98	0.00	6.89	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	50.37	1.23	0.61	0.00	0.31	3.07	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	123.60	2.12	0.53	0.18	0.35	9.74	1.77
Preadipocyte - subcutaneous, donor3	11428-118G6	112.05	2.21	0.85	1.02	0.51	8.34	4.09
Preadipocyte - visceral, donor1	11280-116I2	127.70	1.68	0.28	0.19	0.28	10.53	2.42
Preadipocyte - visceral, donor2	11357-117H7	94.80	2.30	0.00	1.38	0.00	8.74	0.46
Preadipocyte - visceral, donor3	11429-118G7	95.61	2.30	0.63	0.42	0.63	7.63	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	66.38	1.21	0.15	0.30	0.00	5.13	1.06
Prostate Epithelial Cells, donor2	11331-117E8	74.61	2.57	0.41	0.27	0.41	3.52	1.35
Prostate Epithelial Cells, donor3	11404-118D9	44.70	0.12	0.00	0.06	0.00	2.02	1.65
Prostate Stromal Cells, donor1	11254-116F3	80.19	2.39	0.57	0.34	0.34	5.01	1.59
Prostate Stromal Cells, donor2	11332-117E9	91.80	1.43	0.00	0.36	0.00	7.17	2.69
Prostate Stromal Cells, donor3	11405-118E1	65.07	1.98	0.73	0.10	0.00	4.69	2.29
Renal Cortical Epithelial Cells, donor1	11516-119H4	43.80	1.46	0.00	0.00	0.00	2.92	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	73.40	1.52	0.35	0.14	0.14	5.13	0.83
Renal Epithelial Cells, donor1	11517-119H5	36.01	0.00	0.00	0.00	0.00	2.03	0.00
Renal Epithelial Cells, donor2	11597-120H4	27.74	0.71	0.00	0.00	0.00	2.13	0.71
Renal Epithelial Cells, donor3	11678-122H4	88.50	2.22	0.42	0.11	0.21	6.03	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	23.15	0.00	0.00	0.00	0.00	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	49.05	0.13	0.00	0.13	0.00	4.72	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	98.13	0.89	0.00	0.00	0.00	9.32	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	23.29	0.00	0.00	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	44.90	0.22	0.00	0.22	0.00	1.54	0.44
Renal Mesangial Cells, donor2	11598-120H5	42.63	0.00	0.00	0.00	0.00	2.51	1.88
Renal Mesangial Cells, donor3	11679-122H5	24.13	0.00	0.00	0.00	0.00	1.66	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	88.85	1.07	0.00	0.00	0.27	5.64	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	46.81	0.00	0.00	0.00	0.00	2.95	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.80	0.00	0.19	0.00	0.00	3.47	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	79.08	1.30	0.00	0.00	0.00	4.67	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	58.55	0.57	0.00	0.00	0.28	5.12	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	0.00	0.00	0.00	0.00	3.09	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	97.85	0.50	0.25	0.00	0.00	4.77	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	67.22	4.81	0.27	0.13	0.13	3.34	1.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	115.25	0.00	0.00	0.89	1.79	6.25	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	107.32	0.00	0.55	0.55	0.00	5.50	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	99.77	3.48	1.16	0.00	0.00	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	126.77	1.04	0.52	0.13	0.00	7.93	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	116.88	0.79	0.10	0.20	0.20	8.84	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	157.05	1.78	0.33	0.22	0.00	14.39	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	122.43	1.86	0.25	0.87	0.37	11.66	2.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	129.13	0.93	0.23	0.35	0.23	11.89	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	160.64	1.62	0.23	0.46	0.23	14.33	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	107.06	0.96	0.41	0.27	0.00	7.80	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	139.02	0.76	0.61	0.45	0.61	13.31	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	163.24	1.79	0.18	0.36	0.00	15.77	4.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	107.74	0.86	0.00	0.00	0.14	10.19	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	114.72	1.18	0.43	0.11	0.11	9.98	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	129.66	1.33	0.44	0.00	0.22	10.62	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	122.35	1.15	0.19	0.19	0.00	7.46	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	112.35	0.75	0.00	0.09	0.00	9.50	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	189.97	1.50	0.38	0.38	0.19	18.60	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	104.04	0.53	0.00	0.13	0.00	7.96	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	137.93	0.97	0.10	0.10	0.10	9.25	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	139.59	1.72	0.38	0.19	0.00	15.09	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	112.77	0.85	0.00	0.11	0.32	7.37	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	122.77	1.12	0.28	0.28	0.28	11.21	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	129.20	1.20	0.17	0.00	0.34	10.42	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	122.53	0.36	0.00	0.18	0.00	9.66	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	115.15	0.61	0.37	0.25	0.12	9.44	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	138.75	0.94	0.13	0.00	0.13	11.42	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	132.09	0.71	0.94	0.00	0.00	9.20	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	121.63	0.40	0.20	0.40	0.20	9.52	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	146.86	1.64	0.23	0.23	0.00	11.46	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	101.40	0.41	0.21	0.00	0.00	6.22	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	145.78	0.44	0.22	0.44	0.44	10.18	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	123.45	1.25	0.00	0.00	0.00	8.77	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	115.07	0.67	0.13	0.00	0.00	5.65	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	128.91	1.02	0.34	0.00	0.00	11.41	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	146.14	0.96	0.00	0.19	0.00	12.15	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	133.25	0.69	0.00	0.00	0.00	9.80	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	131.54	1.51	0.14	0.27	0.00	9.74	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	141.19	1.15	0.16	0.00	0.16	10.01	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	95.95	1.02	0.00	0.34	0.00	5.28	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	115.70	2.22	0.59	0.30	0.00	11.24	2.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	128.48	1.07	0.53	0.00	0.00	13.06	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	93.47	1.24	0.00	0.14	0.00	9.13	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	118.81	1.19	1.19	0.00	0.00	10.95	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	135.64	2.42	0.00	0.40	0.81	9.88	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	90.78	1.04	0.09	0.09	0.28	7.82	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	131.71	2.10	0.35	0.35	0.35	12.58	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	97.01	0.30	0.30	0.00	0.00	9.67	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	99.38	1.84	0.24	0.12	0.24	8.32	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	164.18	3.49	0.29	0.15	0.15	12.37	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	111.95	2.43	0.00	0.00	0.00	10.34	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	93.13	2.11	0.00	0.30	0.00	6.33	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	115.13	1.36	0.23	0.00	0.45	9.05	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	128.20	1.80	0.30	0.00	0.30	7.79	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	77.81	0.59	0.12	0.00	0.12	6.49	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	137.89	0.64	0.43	0.21	0.21	12.81	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	159.26	1.80	1.20	0.00	0.00	9.62	2.40
Schwann Cells, donor1	11498-119F4	37.24	0.00	0.00	0.00	0.00	2.44	0.38
Schwann Cells, donor2	11578-120F3	71.45	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	64.41	1.97	0.22	0.00	0.00	3.94	1.53
Sebocyte, donor1	11220-116B5	69.02	1.10	0.00	0.00	0.00	4.38	0.55
Sebocyte, donor2	11301-117B5	68.47	0.46	0.00	0.00	0.46	5.06	3.22
Sebocyte, donor3	11378-118B1	46.38	0.21	0.00	0.21	0.00	3.71	1.24
Sertoli Cells, donor1	11255-116F4	84.49	6.63	3.31	0.00	0.00	3.31	8.28
Sertoli Cells, donor2	11333-117F1	146.87	2.82	0.00	5.65	5.65	22.59	0.00
Skeletal Muscle Cells, donor1	11281-116I3	90.88	0.53	0.09	0.09	0.00	9.24	2.20
Skeletal Muscle Cells, donor2	11358-117H8	26.02	0.72	0.00	0.00	0.00	2.89	1.45
Skeletal Muscle Cells, donor3	11430-118G8	56.85	0.00	0.00	0.00	0.00	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	82.95	2.36	0.00	0.63	0.00	5.97	1.73
Skeletal Muscle Cells, donor5	11455-119A6	85.62	2.68	0.30	0.30	0.00	8.03	1.49
Skeletal Muscle Cells, donor6	11459-119B1	104.81	1.54	0.31	0.46	0.15	11.23	2.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	88.46	5.17	0.50	0.13	0.13	7.69	2.52
Skeletal Muscle Satellite Cells, donor2	11321-117D7	92.18	1.28	0.00	0.00	0.14	5.71	2.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	98.32	2.38	0.10	0.10	0.00	8.83	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	81.72	2.78	0.25	0.08	0.51	10.78	2.44
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	44.87	0.00	0.00	0.00	0.00	5.07	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	40.87	0.55	0.41	0.55	0.00	3.16	0.69
Skin - palm, donor1	10286-104F7	75.21	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	58.38	0.58	0.58	0.00	0.14	3.17	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	178.30	0.82	0.00	0.00	0.82	5.73	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	70.50	0.13	0.26	0.00	0.00	5.32	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	74.51	1.39	0.42	0.42	0.56	3.61	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	66.81	0.70	0.14	0.28	0.14	4.08	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	127.92	1.69	0.42	0.42	0.63	6.13	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	45.12	0.37	0.15	0.37	0.07	2.25	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	78.69	1.23	0.93	0.31	0.31	7.41	2.16
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	69.37	1.33	0.67	0.44	0.44	4.22	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	58.78	1.18	0.00	0.00	0.00	4.11	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.00	0.88	0.22	0.00	0.22	3.09	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	38.59	0.00	0.39	0.39	0.00	3.94	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	74.94	0.00	0.00	0.00	0.00	5.41	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	64.05	1.00	0.00	0.00	0.00	4.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	45.38	1.06	0.00	0.53	0.67	4.52	1.60
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	84.89	0.89	1.11	0.00	0.44	4.88	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	99.35	1.92	0.90	0.77	0.13	8.32	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	70.33	3.58	0.00	0.00	0.00	4.56	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	69.40	2.07	0.30	0.59	0.00	6.20	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	67.62	2.99	0.28	0.14	0.14	5.55	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.65	0.00	0.16	0.16	0.00	2.60	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	60.28	0.30	0.30	0.00	0.00	2.74	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	67.18	2.02	0.00	0.51	0.76	3.28	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	37.67	0.00	0.48	1.43	0.00	5.25	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	64.45	2.06	0.59	0.29	0.15	4.42	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	59.19	1.51	0.22	0.22	0.43	4.09	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	70.53	2.31	0.31	0.31	0.00	5.14	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	44.86	1.08	0.15	0.15	0.46	2.47	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	39.88	0.00	1.08	0.00	0.00	3.23	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	53.20	0.90	0.00	0.00	0.60	5.68	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	24.58	0.34	0.00	0.00	0.00	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	73.42	3.06	0.24	0.47	0.39	4.55	1.33
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	118.25	2.92	0.60	0.30	0.40	6.94	2.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	71.91	1.14	0.23	0.23	0.23	5.69	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	35.62	0.60	0.00	0.00	0.00	6.04	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	80.80	2.12	0.26	0.26	0.26	5.03	2.38
Smooth Muscle Cells - Prostate, donor1	11257-116F6	69.24	3.73	0.40	0.13	0.40	5.73	1.73
Smooth Muscle Cells - Prostate, donor2	11335-117F3	95.04	2.88	0.25	0.50	0.25	6.64	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	48.96	1.52	0.25	0.00	0.25	2.28	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	85.04	1.96	0.30	0.60	0.00	6.33	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	39.76	0.00	0.00	0.00	0.00	5.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	46.52	0.00	0.00	0.00	0.00	23.26	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	60.92	2.33	0.00	0.93	0.00	6.51	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	80.28	0.50	0.00	0.00	1.01	5.05	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	52.34	0.63	0.31	0.00	0.00	4.07	2.19
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.07	0.29	0.00	0.00	0.00	1.18	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	75.14	2.25	0.67	0.17	0.08	5.25	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	50.45	1.87	0.93	0.00	0.00	3.27	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	53.97	0.58	0.72	0.43	0.29	3.60	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	51.25	1.27	0.25	0.00	0.00	3.06	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	46.82	0.56	0.19	0.00	0.19	2.44	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	62.61	2.52	0.28	0.28	0.28	4.19	1.68
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	68.62	2.09	0.08	0.25	0.17	4.86	1.26
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	31.43	0.00	0.00	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	36.94	0.98	0.00	0.00	0.00	5.38	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	102.52	1.55	0.88	1.55	0.22	7.07	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	45.06	2.63	0.29	1.17	0.29	1.76	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	45.67	1.36	0.19	0.00	0.00	2.14	1.94
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	66.91	1.59	0.00	0.26	0.00	5.55	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	33.10	3.35	0.74	0.00	0.00	1.49	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	57.85	6.83	0.72	0.00	0.36	2.52	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	67.57	1.14	0.57	0.57	0.00	3.12	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	61.84	0.79	0.00	0.39	0.00	5.12	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	48.00	2.54	0.00	0.25	0.51	1.52	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	54.31	1.60	0.00	0.00	0.00	2.40	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	53.50	1.25	0.42	0.00	0.00	2.93	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	52.71	1.38	0.00	0.00	0.46	2.75	2.75
Synoviocyte, donor1	11291-117A4	100.82	3.03	0.84	0.34	0.17	5.72	2.86
Synoviocyte, donor2	11368-117I9	63.53	2.35	0.00	0.34	0.00	3.86	1.84
Synoviocyte, donor3	11440-118H9	51.61	2.68	0.00	0.22	0.00	3.13	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	47.53	0.36	0.00	0.00	0.00	3.57	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	0.00	0.00	0.00	0.00	7.93	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.33	0.46	0.23	0.00	0.00	2.08	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	49.75	0.36	0.00	0.14	0.00	1.86	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	42.91	0.00	0.00	0.00	0.00	3.09	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	0.57	0.00	0.00	0.00	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	66.93	5.66	0.25	0.25	0.49	4.67	1.97
Urethra, donor2	10319-105A4	115.10	7.19	0.00	0.00	0.00	3.60	1.80
Urothelial Cells, donor1	11520-119H8	35.86	0.00	0.00	0.27	0.00	2.39	0.00
Urothelial Cells, donor2	11600-120H7	23.23	0.00	0.00	0.00	0.00	0.80	0.80
Urothelial Cells, donor3	11681-122H7	26.36	0.00	0.00	0.00	0.00	1.60	0.00
Urothelial cells, donor0	11216-116B1	62.63	1.34	0.00	0.00	0.00	2.45	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	71.18	4.45	0.00	0.00	0.00	2.67	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	64.33	0.00	0.00	0.00	0.00	7.15	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	51.34	0.00	0.00	0.00	0.00	2.74	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	67.49	0.00	0.00	0.00	0.00	2.75	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	77.86	0.58	0.00	0.00	0.00	5.23	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	1.04	0.00	0.00	0.00	5.21	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	58.74	4.59	0.00	0.00	0.00	3.67	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	46.56	2.74	0.00	0.00	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	90.92	0.25	0.00	0.12	0.00	6.78	1.60
Wilms' tumor cell line:HFWT	10597-108E3	110.01	0.88	0.00	0.00	0.00	6.16	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	112.57	1.40	0.00	0.00	0.00	8.66	1.40
achilles tendon, donor2	10292-104G4	49.60	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	113.20	0.76	0.00	0.00	0.00	13.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	107.26	1.39	0.00	0.46	0.00	10.68	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	239.20	2.02	0.00	0.71	0.12	37.51	2.61
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	249.26	0.27	0.00	0.00	0.54	23.67	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	64.37	0.00	0.28	0.00	0.00	5.62	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	119.49	8.67	0.42	0.21	0.42	9.73	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	110.79	1.09	0.27	0.27	0.00	9.53	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	129.55	1.32	0.00	0.44	0.00	10.58	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	106.17	1.63	0.00	0.00	0.00	8.58	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	161.53	4.66	0.00	0.00	0.00	21.36	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	130.46	0.18	0.00	0.37	0.18	10.49	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	127.81	3.25	0.23	0.46	0.23	10.46	2.56
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	222.91	2.85	0.00	0.26	0.00	20.71	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	248.41	1.46	0.00	0.58	0.00	25.13	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	51.12	0.93	0.00	0.00	0.00	3.25	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	99.11	0.00	0.00	0.00	0.41	4.94	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	142.12	0.31	0.00	0.00	0.00	8.90	2.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	107.96	2.56	0.00	0.00	0.00	5.12	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	114.95	1.82	0.30	0.30	0.30	6.07	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	113.61	1.93	0.00	0.00	0.00	7.94	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	77.07	0.00	0.00	0.00	0.00	9.13	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	83.05	1.33	0.00	1.00	0.00	6.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	105.92	5.57	0.00	1.86	0.00	5.57	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	132.58	0.38	0.00	0.00	0.00	9.04	3.77
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	110.78	1.31	0.44	0.44	0.00	12.21	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	67.48	1.87	0.00	0.00	0.00	11.25	1.87
adenocarcinoma cell line:IM95m	10796-110I4	156.61	1.18	0.47	0.00	0.24	13.19	2.83
adipose tissue, adult, pool1	10010-101C1	66.86	2.48	0.16	0.00	0.00	1.09	1.55
adipose, donor1	10184-103D4	112.00	21.11	2.35	0.59	0.59	4.69	1.76
adipose, donor2	10185-103D5	187.35	2.03	0.81	0.81	0.81	6.08	6.89
adipose, donor3	10186-103D6	151.12	1.91	0.27	0.54	0.27	6.81	5.17
adipose, donor4	10187-103D7	123.08	1.73	0.00	0.00	0.00	14.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.71	0.32	0.00	0.16	0.00	5.37	1.58
adrenal gland, adult, pool1	10081-102A9	141.87	0.00	0.00	0.00	0.00	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	104.72	0.40	0.13	0.27	0.00	7.60	1.73
alveolar cell carcinoma cell line:SW 1573	10708-109H6	62.17	0.00	0.36	0.00	0.00	4.64	0.36
amniotic membrane cells, donor1	12235-129G3	56.80	0.93	0.23	0.23	0.93	1.39	3.48
amniotic membrane cells, donor2	12236-129G4	41.25	5.41	1.01	1.01	0.00	0.68	1.69
amniotic membrane cells, donor3	12237-129G5	42.72	1.18	0.00	0.00	1.18	2.36	2.65
amygdala - adult, donor10196	10167-103B5	84.19	4.74	0.00	2.37	1.19	4.74	13.04
amygdala, adult, donor10252	10151-102I7	90.43	5.88	1.22	0.61	1.01	2.03	5.47
amygdala, newborn, donor10223	10360-105E9	84.57	2.90	0.32	0.65	1.61	2.26	4.52
anaplastic carcinoma cell line:8305C	10428-106D5	91.30	0.51	0.38	0.00	0.13	7.39	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	146.05	0.88	0.44	0.22	0.00	11.91	2.87
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	242.18	1.67	0.00	0.67	0.00	22.71	5.01
aorta, adult, pool1	10052-101G7	66.10	0.98	0.00	0.39	0.20	2.35	2.94
appendix, adult	10189-103D9	118.76	3.88	0.78	0.39	0.00	9.31	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	228.03	7.22	0.34	0.69	0.69	17.88	3.10
artery, adult	10190-103E1	130.43	8.15	1.36	0.00	0.00	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	81.27	1.01	0.43	0.14	0.14	5.50	2.03
b cell line:RPMI1788	10427-106D4	99.48	1.04	0.45	0.59	0.30	9.07	2.53
basal cell carcinoma cell line:TE 354.T	10702-109G9	114.86	3.88	0.83	1.11	0.83	8.88	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	86.43	0.99	0.30	0.10	0.10	9.23	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	86.87	1.00	0.00	0.17	0.00	5.02	1.51
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	127.51	0.56	0.00	0.00	0.56	17.34	1.12
bladder, adult, pool1	10011-101C2	76.92	3.80	0.00	0.00	0.11	1.96	2.17
blood, adult, pool1	10053-101G8	57.58	2.21	0.00	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	78.78	1.71	0.00	0.00	0.00	3.43	2.57
bone marrow, adult	10192-103E3	99.20	4.05	0.00	0.00	0.67	2.02	5.40
brain, adult, donor1	10084-102B3	109.68	4.10	1.03	1.03	2.05	3.08	10.25
brain, adult, pool1	10012-101C3	79.18	6.90	2.56	3.23	1.78	3.12	6.79
brain, fetal, pool1	10085-102B4	88.16	0.00	0.00	0.00	0.00	8.01	5.34
breast carcinoma cell line:MCF7	10482-107A5	105.72	2.31	0.33	0.00	0.33	4.63	2.31
breast carcinoma cell line:MDA-MB-453	10419-106C5	150.91	4.37	0.75	0.37	0.50	4.24	2.00
breast, adult, donor1	10080-102A8	93.44	2.53	0.00	0.00	0.00	4.42	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	98.58	1.78	0.25	1.27	0.38	5.34	2.54
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	163.58	0.62	0.31	0.00	0.62	12.06	5.26
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	100.84	1.15	0.23	0.00	0.23	6.45	2.53
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	105.55	0.24	0.00	0.00	0.24	7.50	2.18
carcinoid cell line:NCI-H1770	10703-109H1	69.58	0.00	0.00	0.47	0.47	2.82	0.47
carcinoid cell line:NCI-H727	10735-110B6	83.68	1.64	0.22	0.11	0.00	6.45	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	128.03	1.27	0.00	0.63	0.63	6.97	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	108.33	2.40	0.53	0.53	0.53	5.32	3.73
caudate nucleus - adult, donor10196	10177-103C6	78.29	5.76	1.15	2.30	0.00	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	87.51	3.85	0.33	1.67	0.67	2.18	6.19
caudate nucleus, adult, donor10258	10379-105H1	129.90	0.76	0.76	0.00	0.76	0.76	10.70
caudate nucleus, newborn, donor10223	10354-105E3	111.33	3.30	2.56	0.73	0.73	3.30	3.66
cerebellum - adult, donor10196	10173-103C2	75.75	11.65	0.00	2.91	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	87.33	7.69	1.71	2.56	1.92	3.20	4.06
cerebellum, adult, pool1	10083-102B2	60.02	5.86	1.38	2.76	0.00	3.45	4.14
cerebellum, newborn, donor10223	10357-105E6	83.86	4.98	1.66	0.00	0.83	3.32	2.49
cerebral meninges, adult	10188-103D8	106.40	6.56	1.76	1.76	1.76	2.27	6.05
cerebrospinal fluid, donor2	10294-104G6	135.94	1.46	2.92	1.46	0.73	4.39	0.73
cervical cancer cell line:D98-AH2	10552-107I3	87.56	0.72	0.14	0.58	0.00	13.95	2.30
cervical cancer cell line:ME-180	10553-107I4	71.09	2.65	0.50	0.00	0.33	1.66	1.49
cervix, adult, pool1	10013-101C4	66.14	2.31	0.31	0.42	0.21	3.15	2.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.15	0.14	0.14	0.00	0.00	2.79	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	92.74	0.00	0.00	0.00	0.00	6.53	2.61
choriocarcinoma cell line:BeWo	10423-106C9	160.56	5.47	0.75	0.25	0.12	16.53	1.49
choriocarcinoma cell line:SCH	10785-110H2	49.28	1.72	0.62	0.37	0.37	3.94	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	51.70	0.95	0.00	0.00	0.00	3.56	0.71
chorionic membrane cells, donor1	12238-129G6	53.00	1.99	0.00	0.00	0.00	2.85	1.71
chorionic membrane cells, donor2	12239-129G7	80.94	3.18	0.30	0.20	0.20	4.57	2.29
chorionic membrane cells, donor3	12240-129G8	54.95	3.30	0.55	0.00	0.00	2.75	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	128.24	1.01	1.01	2.02	1.01	8.08	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	126.79	1.92	0.38	0.00	0.00	11.91	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	150.79	2.96	0.00	0.00	0.00	10.35	3.17
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	83.97	0.77	0.26	0.00	0.00	7.96	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	81.51	1.69	0.48	0.48	0.00	7.01	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.20	1.02	0.41	0.20	0.00	7.94	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	189.92	0.00	0.00	0.59	0.00	15.31	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	219.97	1.04	0.00	0.00	0.00	22.67	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	106.98	0.00	0.23	0.23	0.23	5.71	2.97
clear cell carcinoma cell line:TEN	10636-108I6	111.56	3.30	0.87	0.52	0.69	10.24	2.78
colon carcinoma cell line:CACO-2	10513-107D9	98.11	1.83	0.18	0.00	0.00	6.41	1.83
colon carcinoma cell line:COLO-320	10420-106C6	193.84	1.52	0.38	0.00	0.38	15.58	3.80
colon, adult, donor1	10082-102B1	145.18	2.38	0.00	1.19	0.00	4.76	5.95
colon, adult, pool1	10014-101C5	94.36	3.06	0.24	0.00	0.00	6.11	1.53
colon, fetal, donor1	10070-101I7	148.32	3.71	0.00	0.00	0.00	4.33	8.65
common myeloid progenitor CMP, donor1	12130-128D6	192.51	0.00	0.00	0.00	0.00	9.17	4.58
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	343.35	2.97	1.70	0.42	1.27	23.80	5.10
cord blood derived cell line:COBL-a 24h infection	10453-106G3	241.49	1.81	0.75	0.45	0.30	20.38	2.87
cord blood derived cell line:COBL-a untreated	10449-106F8	251.14	2.26	0.56	0.42	0.28	24.39	2.82
corpus callosum, adult, pool1	10042-101F6	108.02	7.96	1.99	1.55	1.33	5.20	4.09
cruciate ligament, donor2	10295-104G7	64.03	0.00	0.00	0.00	0.00	3.24	2.43
diaphragm, fetal, donor1	10069-101I6	118.78	6.42	2.41	0.00	0.00	6.42	8.03
diencephalon, adult	10193-103E4	74.40	3.36	1.68	2.16	2.40	2.88	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	117.56	0.69	0.46	0.46	0.23	13.78	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	105.65	0.26	0.26	0.00	0.00	9.74	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	100.62	0.72	0.48	0.72	0.24	5.30	0.48
ductus deferens, adult	10196-103E7	68.27	2.49	0.00	0.50	0.00	3.49	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	120.98	2.88	0.00	0.00	1.44	11.52	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	82.39	5.15	0.74	0.00	1.47	5.15	2.21
dura mater, adult, donor1	10041-101F5	52.69	1.40	0.33	0.08	0.08	1.82	1.82
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	132.58	0.44	0.00	0.44	0.00	12.21	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	131.40	0.29	0.00	0.00	0.14	10.17	1.58
embryonic pancreas cell line:1B2C6	10604-108F1	72.14	0.00	0.00	0.00	0.00	2.47	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	78.40	0.00	0.00	0.00	0.00	3.33	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	89.54	0.00	0.00	0.00	0.00	4.32	2.47
embryonic pancreas cell line:2C6	10603-108E9	84.06	0.00	0.00	0.00	0.00	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	146.82	1.34	0.00	0.67	0.34	9.72	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	153.51	1.45	0.72	0.36	0.18	8.70	6.16
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	114.66	1.45	0.64	0.16	0.00	8.52	2.25
epidermoid carcinoma cell line:A431	10426-106D3	115.94	2.22	0.11	0.22	0.00	9.67	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.91	0.77	0.11	0.22	0.11	7.70	0.88
epididymis, adult	10197-103E8	79.54	3.98	0.21	0.42	0.42	2.93	3.35
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	46.48	0.53	0.00	0.00	0.00	2.48	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	95.95	0.00	0.00	0.00	0.00	2.75	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	92.00	0.92	0.39	0.00	0.13	7.08	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	94.19	1.28	0.39	0.20	0.10	8.56	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	92.87	1.12	0.22	0.11	0.11	7.62	1.46
esophagus, adult, pool1	10015-101C6	59.67	1.70	0.11	0.11	0.00	3.08	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	109.33	0.25	0.25	1.25	0.13	6.89	4.26
eye - muscle inferior rectus, donor1	10272-104E2	132.80	2.41	0.00	0.00	0.00	7.24	2.41
eye - muscle lateral, donor2	10298-104H1	113.63	0.00	0.00	0.00	2.10	2.10	4.21
eye - muscle medial, donor2	10299-104H2	144.36	1.49	0.00	0.00	2.98	10.42	2.98
eye - muscle superior, donor2	10297-104G9	100.89	2.29	0.00	0.00	1.15	5.73	2.29
eye - vitreous humor, donor1	10268-104D7	33.52	0.00	1.46	2.91	0.00	1.46	2.91
eye, fetal, donor1	10054-101G9	69.41	5.85	0.76	0.51	1.02	4.07	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	112.20	0.38	0.00	0.00	0.00	11.67	2.56
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	85.95	0.47	0.24	0.00	0.00	5.46	0.95
frontal lobe, adult, pool1	10040-101F4	90.82	5.91	2.91	1.97	2.63	3.47	6.29
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	107.79	1.20	0.30	0.00	0.30	6.31	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	75.25	0.37	0.18	0.18	0.09	4.30	2.19
gall bladder, adult	10198-103E9	100.68	1.93	0.24	0.00	0.00	2.17	2.17
gamma delta positive T cells, donor1	11937-126A2	180.38	0.00	0.00	0.00	0.00	4.29	4.83
gamma delta positive T cells, donor2	11938-126A3	138.94	2.24	0.37	0.00	0.00	7.10	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	140.04	2.53	0.63	0.42	0.00	8.24	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	49.13	0.19	0.00	0.00	0.00	3.48	0.77
gastric cancer cell line:AZ521	10549-107H9	106.24	2.79	0.00	0.16	0.00	15.41	2.13
gastric cancer cell line:GSS	10560-108A2	112.57	0.92	0.00	0.00	0.00	4.58	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	79.50	1.60	0.23	0.00	0.00	7.08	1.14
giant cell carcinoma cell line:LU65	10487-107B1	101.89	0.00	0.00	0.00	0.00	5.39	1.38
giant cell carcinoma cell line:Lu99B	10433-106E1	97.13	1.12	0.14	0.14	0.28	4.48	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	89.04	1.00	0.00	0.50	0.25	4.74	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	47.18	0.63	0.21	0.11	0.00	2.96	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	57.44	0.98	0.14	0.00	0.14	4.35	1.12
glioblastoma cell line:T98G	10485-107A8	71.19	4.86	0.33	0.55	0.11	3.75	1.21
glioma cell line:GI-1	10413-106B8	63.85	1.46	0.29	0.29	0.88	4.39	3.22
globus pallidus - adult, donor10196	10175-103C4	94.03	4.37	1.46	0.00	2.19	2.92	4.37
globus pallidus, adult, donor10252	10161-103A8	106.43	6.35	3.17	2.20	1.22	4.64	4.39
globus pallidus, adult, donor10258	10367-105F7	58.88	2.74	0.00	2.74	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	110.31	3.20	0.53	0.00	0.00	2.13	4.26
granulocyte macrophage progenitor, donor1	12131-128D7	225.14	4.89	0.00	0.00	0.00	19.58	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	99.84	1.92	0.00	0.00	0.64	4.80	2.24
hIPS +CCl2, biol_rep1	14383-156B9	107.43	1.38	0.00	0.46	0.46	11.02	1.84
hIPS +CCl2, biol_rep2	14384-156C1	96.48	0.46	0.00	0.00	0.00	8.23	0.46
hIPS +CCl2, biol_rep3	14385-156C2	117.22	1.93	0.00	0.00	0.00	3.86	0.64
hIPS, biol_rep1	14380-156B6	94.86	0.00	0.00	0.00	0.00	8.62	0.00
hIPS, biol_rep2	14381-156B7	127.57	2.06	0.00	0.00	0.00	10.29	0.69
hIPS, biol_rep3	14382-156B8	67.31	4.41	2.21	1.10	1.10	5.52	0.00
hairy cell leukemia cell line:Mo	10712-109I1	109.48	0.57	0.57	0.29	0.57	3.74	2.30
heart - mitral valve, adult	10205-103F7	68.16	5.08	0.00	0.60	0.30	2.09	2.99
heart - pulmonic valve, adult	10206-103F8	69.03	5.75	0.78	1.57	0.52	3.14	2.09
heart - tricuspid valve, adult	10207-103F9	62.45	1.67	0.00	0.00	0.00	3.33	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	79.38	2.04	0.20	0.82	0.20	5.51	2.65
heart, adult, diseased, donor1	10051-101G6	107.74	2.13	2.13	0.00	0.43	2.55	1.28
heart, adult, pool1	10016-101C7	121.43	5.75	2.07	0.69	0.92	5.98	4.14
heart, fetal, pool1	10046-101G1	111.82	7.39	1.33	0.62	0.41	4.52	3.49
hepatic mesenchymal tumor cell line:LI90	10778-110G4	98.42	1.85	0.00	1.23	0.00	9.87	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	46.38	0.00	0.00	0.00	0.00	5.95	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	84.53	1.88	0.44	0.22	0.22	5.30	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	86.66	1.58	0.36	0.36	0.24	7.04	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	97.31	2.83	0.10	0.30	0.00	6.77	1.21
hepatoma cell line:Li-7	10484-107A7	118.33	0.78	0.22	0.22	0.11	7.12	1.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	101.81	0.10	0.20	0.10	0.30	15.18	0.70
hippocampus - adult, donor10196	10169-103B7	95.58	2.84	1.89	0.00	0.95	1.89	7.57
hippocampus, adult, donor10252	10153-102I9	103.27	7.55	1.22	1.43	1.22	4.69	6.12
hippocampus, adult, donor10258	10374-105G5	65.23	2.99	2.49	1.00	1.99	1.00	2.49
hippocampus, newborn, donor10223	10363-105F3	129.36	2.11	0.00	0.70	1.06	3.88	6.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	208.13	3.66	0.00	0.00	0.00	21.36	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	190.46	0.39	0.00	0.00	0.00	21.99	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	229.01	2.29	0.00	0.00	0.25	18.79	2.54
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	150.55	3.95	0.56	0.00	0.00	5.07	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	174.29	5.68	0.52	0.00	0.26	7.49	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	130.97	4.18	0.00	0.00	0.00	6.83	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	138.68	2.63	0.88	0.29	0.29	2.92	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	167.39	3.88	0.22	0.43	0.00	7.11	4.74
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	144.31	1.67	0.00	0.00	0.83	6.67	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	117.69	5.21	0.71	0.47	0.24	4.74	3.79
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	144.81	3.54	0.48	0.16	0.64	8.04	5.14
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	162.27	5.39	0.67	1.35	0.67	4.04	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	174.01	1.88	0.16	0.00	0.00	18.31	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	119.38	0.98	0.49	0.00	0.00	16.70	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	150.99	1.75	0.00	0.00	0.00	10.47	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	197.59	7.64	0.19	0.00	0.19	7.45	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	139.98	4.80	0.87	0.00	0.00	7.85	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	110.45	10.00	1.00	0.00	0.50	7.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	158.06	1.88	0.38	0.57	0.38	5.46	7.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	169.61	1.82	0.91	1.82	0.45	7.73	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	146.59	1.25	0.94	1.25	1.25	7.20	5.64
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	134.07	3.59	0.33	0.33	0.00	4.41	4.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	124.54	3.19	0.00	0.00	0.29	6.39	5.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	133.32	3.59	0.60	0.00	1.49	6.88	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	203.40	1.11	0.00	0.00	0.00	21.80	2.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	188.86	1.71	0.29	0.00	0.29	21.97	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	168.63	2.45	0.82	0.41	0.00	18.37	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	105.98	3.17	0.35	0.00	0.70	6.69	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	150.45	3.48	0.00	0.63	0.00	6.97	3.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	124.98	3.63	0.00	0.00	0.30	8.17	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	123.59	3.62	0.52	0.00	1.03	5.69	6.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	153.42	1.99	1.33	1.99	0.66	5.31	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	96.97	2.31	0.26	0.51	0.00	3.33	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	113.51	3.07	0.77	0.77	0.77	7.67	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	149.93	3.79	0.76	0.76	0.76	11.36	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	145.51	6.05	0.00	0.00	0.67	4.03	4.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	163.50	1.45	0.00	0.00	0.48	15.46	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	159.10	1.78	0.45	0.00	0.00	20.95	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	222.44	1.46	0.00	0.00	0.00	20.98	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	136.00	5.81	0.31	0.61	0.00	5.50	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	243.99	45.55	0.00	3.25	3.25	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	106.56	10.26	0.66	0.00	0.33	3.64	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	119.31	2.19	0.55	0.00	0.55	4.38	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	118.34	3.26	0.00	0.36	0.00	2.17	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	100.00	2.49	0.36	0.00	0.36	3.20	2.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	143.21	3.58	0.00	0.00	0.00	4.77	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	123.37	5.96	0.00	0.41	0.14	5.28	4.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	119.34	3.23	0.00	0.54	0.00	4.58	2.16
immature langerhans cells, donor1	11904-125F5	71.92	1.45	0.00	0.48	0.24	3.87	0.97
immature langerhans cells, donor2	11905-125F6	61.79	0.79	0.00	0.00	0.00	2.38	1.58
insula, adult, pool1	10039-101F3	109.68	6.44	2.65	1.89	2.74	4.16	8.23
keratoacanthoma cell line:HKA-1	10791-110H8	104.37	0.33	0.00	0.33	0.33	6.50	3.58
kidney, adult, pool1	10017-101C8	88.11	4.01	0.90	0.20	0.50	3.80	3.40
kidney, fetal, pool1	10045-101F9	76.61	2.48	1.20	0.28	0.50	3.25	2.05
large cell lung carcinoma cell line:IA-LM	10509-107D5	177.24	0.57	0.00	0.28	0.14	12.21	1.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	62.90	0.41	0.00	0.14	0.00	13.27	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	43.31	0.55	0.37	0.18	0.18	2.39	0.37
left atrium, adult, donor1	10079-102A7	106.79	5.99	2.18	1.63	0.54	2.18	3.27
left ventricle, adult, donor1	10078-102A6	131.47	2.53	1.52	0.51	0.00	3.03	7.58
leiomyoblastoma cell line:G-402	10721-110A1	134.89	0.27	0.00	0.00	0.00	10.67	3.56
leiomyoma cell line:10964C	10569-108B2	57.12	1.80	0.00	0.36	0.36	1.08	1.80
leiomyoma cell line:15242A	10570-108B3	90.76	1.63	0.00	0.00	0.00	4.89	1.09
leiomyoma cell line:15425	10571-108B4	65.80	0.97	0.24	0.49	0.24	1.94	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	63.49	0.00	0.00	0.00	0.00	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	72.14	0.00	0.00	0.00	0.00	4.18	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	101.77	0.24	0.24	0.24	0.00	10.86	2.01
liposarcoma cell line:KMLS-1	10782-110G8	93.41	2.19	0.78	0.78	0.00	6.25	2.97
liposarcoma cell line:SW 872	10726-110A6	87.36	0.73	0.12	0.24	0.24	6.21	1.46
liver, adult, pool1	10018-101C9	79.09	2.43	0.00	0.16	0.16	2.27	1.46
liver, fetal, pool1	10086-102B5	63.97	0.94	0.00	0.00	0.00	3.76	1.88
locus coeruleus - adult, donor10196	10182-103D2	119.43	7.15	2.92	1.75	3.50	3.79	4.37
locus coeruleus, adult, donor10252	10165-103B3	75.85	7.57	1.48	1.11	1.48	1.85	3.14
locus coeruleus, adult, donor10258	10375-105G6	123.86	3.95	0.85	1.97	1.69	5.36	6.21
locus coeruleus, newborn, donor10223	10362-105F2	62.67	6.31	2.10	1.68	3.79	0.84	2.94
lung adenocarcinoma cell line:A549	10499-107C4	62.28	0.55	0.00	0.14	0.00	9.00	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	67.56	2.07	2.76	0.00	0.00	3.45	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	72.76	0.66	0.26	0.26	0.13	5.27	1.98
lung, adult, pool1	10019-101D1	65.44	2.13	0.12	0.35	0.00	1.77	1.42
lung, fetal, donor1	10068-101I5	151.84	7.42	0.57	0.57	2.00	6.28	2.85
lung, right lower lobe, adult, donor1	10075-102A3	124.18	1.83	0.92	0.00	0.46	1.83	4.58
lymph node, adult, donor1	10077-102A5	81.89	2.37	0.00	0.00	0.00	4.73	0.95
lymphangiectasia cell line:DS-1	10727-110A7	120.77	0.66	0.22	0.22	0.22	14.25	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	173.72	0.45	0.00	0.60	0.15	11.17	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	108.74	1.70	0.00	0.00	0.00	6.80	1.70
mature adipocyte, donor1	12231-129F8	132.31	5.33	0.44	0.00	0.00	0.89	1.78
mature adipocyte, donor2	12232-129F9	96.50	8.92	0.42	0.42	0.21	2.70	2.70
mature adipocyte, donor3	12233-129G1	104.54	3.56	0.00	0.24	0.47	2.37	1.42
mature adipocyte, donor4	12234-129G2	108.45	8.16	0.53	0.26	0.00	4.74	4.47
maxillary sinus tumor cell line:HSQ-89	10414-106B9	124.37	1.43	0.71	0.24	0.24	4.29	4.29
medial frontal gyrus - adult, donor10196	10170-103B8	64.30	4.51	2.26	0.00	5.64	3.38	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	101.33	7.91	2.21	1.84	1.84	3.49	4.23
medial frontal gyrus, adult, donor10258	10368-105F8	85.46	3.49	3.18	0.64	2.22	1.91	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	58.43	3.41	1.71	0.43	0.85	1.28	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	124.03	5.74	4.05	3.21	2.53	2.36	7.43
medial temporal gyrus, adult, donor10252	10156-103A3	95.71	4.67	1.27	0.85	0.85	1.91	5.52
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	65.49	3.85	1.93	3.85	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	172.24	86.12	0.00	0.00	28.71	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	98.35	2.15	1.08	0.00	0.36	3.59	4.67
medulla oblongata - adult, donor10196	10174-103C3	84.37	12.33	2.60	0.00	0.65	7.14	4.54
medulla oblongata, adult, donor10252	10155-103A2	86.07	11.92	2.63	1.86	2.32	2.17	3.72
medulla oblongata, adult, pool1	10038-101F2	83.10	9.39	2.61	2.37	2.12	3.43	3.18
medulla oblongata, newborn, donor10223	10361-105F1	89.57	8.68	1.74	2.43	2.43	3.82	1.74
medulloblastoma cell line:D283 Med	10838-111E1	170.49	2.66	0.44	0.44	0.89	12.62	2.21
medulloblastoma cell line:ONS-76	10759-110E3	42.06	0.24	0.00	0.00	0.00	3.67	0.98
melanoma cell line:COLO 679	10514-107E1	149.06	1.15	0.72	0.29	0.00	17.25	2.30
melanoma cell line:G-361	10465-106H6	253.55	5.16	2.17	0.54	1.63	30.40	2.44
meningioma cell line:HKBMM	10691-109F7	82.31	0.18	0.00	0.00	0.00	5.97	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	117.19	4.41	0.88	0.00	0.00	6.17	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	149.57	4.41	0.26	1.04	0.52	10.37	4.15
mesenchymal precursor cell - adipose, donor1	11747-123G1	77.79	3.68	0.31	0.61	0.77	7.98	2.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	42.72	2.18	0.36	0.18	0.36	4.18	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	57.15	2.48	0.00	0.41	0.83	4.56	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	36.94	1.12	0.00	0.42	0.28	2.95	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	39.67	1.54	0.58	0.00	0.19	2.70	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	72.88	1.39	0.00	0.00	0.00	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	47.71	1.20	0.34	0.34	0.17	3.95	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	52.79	1.61	0.46	0.46	0.46	5.29	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	55.44	2.65	0.66	0.27	0.27	5.04	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	64.68	2.57	0.27	0.95	0.00	4.86	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	62.17	2.99	0.14	0.43	0.28	4.84	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	54.01	0.99	0.00	0.00	0.00	6.26	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	57.56	1.94	0.28	0.69	0.28	5.40	2.21
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	73.66	2.09	1.05	0.70	0.00	3.14	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	47.57	1.02	0.82	0.61	0.61	3.47	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	59.31	2.16	0.00	0.72	0.36	4.31	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	36.93	1.76	0.21	0.31	0.41	3.41	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	68.40	1.37	0.23	0.23	0.68	5.47	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	95.66	0.84	0.42	0.42	0.84	6.29	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	51.85	3.89	0.15	0.45	0.15	4.18	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	52.08	2.01	0.18	0.53	0.09	4.29	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	73.63	2.21	0.00	0.74	0.74	3.31	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	75.55	2.29	0.57	0.29	0.29	3.72	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	107.78	2.95	0.42	0.00	0.00	4.63	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	69.41	2.28	1.37	0.46	0.46	5.02	2.74
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	64.71	2.56	0.51	0.51	0.26	2.81	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	79.31	4.45	0.52	0.79	0.26	4.71	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	80.41	0.62	0.31	0.62	0.00	6.16	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	57.90	3.29	0.47	0.24	0.47	3.06	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	72.09	1.35	0.68	0.00	0.34	1.69	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	74.27	1.57	0.00	0.39	0.39	4.32	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	75.53	0.93	0.00	0.93	0.00	2.78	2.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	92.58	2.31	1.15	0.00	0.00	5.19	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	66.93	2.45	0.22	0.22	0.45	5.13	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	73.79	2.64	0.24	0.24	0.00	5.29	3.85
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	83.60	2.93	0.73	0.73	0.00	6.60	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	70.15	1.68	0.00	0.00	0.67	5.37	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	84.74	1.23	0.00	1.23	0.00	6.55	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	89.78	3.44	0.00	0.00	0.43	4.73	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	98.44	0.00	0.00	2.73	0.00	8.20	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	0.00	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	71.13	1.95	0.32	0.65	0.00	4.87	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	104.76	2.91	0.00	0.00	0.00	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	110.88	1.60	0.00	0.00	0.00	5.33	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	97.31	3.27	0.00	0.82	0.00	6.54	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	98.73	0.78	0.00	0.00	0.00	4.66	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	104.94	0.00	0.00	0.00	0.00	4.20	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	72.52	3.97	0.00	0.00	0.00	6.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	0.00	0.00	0.00	0.00	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	71.16	2.96	1.19	0.59	0.00	2.96	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	88.95	3.66	0.00	0.00	0.00	3.66	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	90.57	1.90	1.27	0.00	0.63	7.60	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	91.40	4.48	0.69	0.00	0.00	4.48	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	103.16	4.30	0.00	0.00	0.00	12.90	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	3.99	0.00	0.00	0.00	7.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	72.32	3.44	0.00	0.00	0.00	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	47.27	4.07	0.00	0.00	0.00	4.48	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	52.43	7.94	0.00	0.00	0.79	3.97	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	45.39	4.13	0.00	0.00	0.00	4.72	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	54.24	4.99	0.31	0.00	0.00	3.12	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	65.50	8.02	0.00	0.00	0.00	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	86.34	2.37	0.00	0.00	0.00	4.73	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	77.04	2.57	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	92.93	2.07	0.00	0.00	0.69	3.44	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	92.03	7.42	0.49	0.00	0.00	2.47	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	82.99	0.00	0.00	0.00	0.00	5.61	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	104.31	2.54	0.00	0.00	0.00	2.54	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	85.43	6.45	0.81	0.00	0.00	3.22	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	0.00	2.18	0.00	0.00	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	58.28	2.53	0.00	0.00	0.00	5.07	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	64.33	2.43	0.61	0.00	0.61	3.64	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	112.97	0.00	0.00	0.00	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	74.13	3.29	0.00	0.82	0.00	5.77	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	105.96	5.75	0.60	0.00	0.20	5.56	3.37
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	75.61	4.22	0.32	0.32	0.00	3.89	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	86.58	5.09	1.02	0.00	2.04	5.09	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	83.56	3.87	0.00	0.00	0.00	1.55	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	116.23	0.00	0.24	0.00	0.00	6.85	3.07
mesothelioma cell line:ACC-MESO-4	10494-107B8	132.29	5.56	1.39	0.46	0.93	9.04	2.55
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	0.00	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	40.48	0.51	0.10	0.00	0.00	2.67	0.62
mesothelioma cell line:Mero-25	10850-111F4	48.80	0.23	0.00	0.00	0.00	3.18	0.23
mesothelioma cell line:Mero-41	10851-111F5	82.39	0.98	0.00	0.00	0.00	4.16	2.20
mesothelioma cell line:Mero-48a	10852-111F6	57.13	1.11	0.00	0.22	0.00	5.09	0.66
mesothelioma cell line:Mero-82	10853-111F7	129.83	1.84	0.00	0.00	0.53	12.35	1.05
mesothelioma cell line:Mero-83	10854-111F8	50.22	2.04	0.00	0.17	0.51	3.92	1.36
mesothelioma cell line:Mero-84	10855-111F9	51.82	0.00	0.00	0.00	0.00	2.02	0.51
mesothelioma cell line:Mero-95	10856-111G1	74.74	2.48	0.00	0.21	0.00	6.00	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	76.36	1.16	0.17	0.17	0.33	5.96	0.50
mesothelioma cell line:NCI-H226	10846-111E9	55.93	0.54	0.18	0.00	0.00	8.33	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	51.59	3.76	0.00	0.17	0.00	2.39	1.20
mesothelioma cell line:NCI-H28	10845-111E8	50.13	0.76	0.00	0.76	0.00	2.54	0.25
mesothelioma cell line:No36	10857-111G2	52.19	0.98	0.00	0.33	0.65	2.28	0.00
mesothelioma cell line:ONE58	10858-111G3	68.28	0.81	0.00	0.00	0.00	4.06	0.00
migratory langerhans cells, donor1	11901-125F2	442.96	8.64	0.96	0.38	0.96	27.83	2.49
migratory langerhans cells, donor2	11902-125F3	312.13	5.86	1.34	0.12	0.61	20.64	3.54
migratory langerhans cells, donor3	11903-125F4	507.03	5.03	1.26	0.36	0.36	52.95	4.31
mixed mullerian tumor cell line:HTMMT	10689-109F5	99.25	0.98	0.00	0.00	0.00	5.88	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	90.07	1.27	0.64	0.85	0.64	5.72	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	84.31	0.23	0.00	0.00	0.00	10.14	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	153.95	1.14	1.71	0.38	0.00	11.04	1.71
myelodysplastic syndrome cell line:SKM-1	10772-110F7	175.18	2.22	0.00	0.00	0.18	16.26	2.40
myeloma cell line:PCM6	10474-106I6	123.15	1.38	0.00	0.20	0.00	5.73	2.77
myxofibrosarcoma cell line:MFH-ino	10600-108E6	77.11	0.00	0.00	0.00	0.00	8.62	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	82.18	0.59	0.00	0.20	0.20	5.88	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	53.60	0.33	0.11	0.00	0.00	2.12	1.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	60.89	0.37	0.00	0.15	0.15	2.13	1.03
nasal epithelial cells, donor2	12227-129F4	83.90	1.10	0.00	0.00	0.00	3.86	3.31
neuroblastoma cell line:CHP-134	10508-107D4	129.52	2.07	0.23	0.23	0.23	18.17	2.07
neuroblastoma cell line:NB-1	10539-107G8	187.27	1.68	0.75	0.94	0.75	22.08	4.12
neuroblastoma cell line:NBsusSR	10607-108F4	58.84	1.48	0.42	0.00	0.21	4.22	1.05
neuroblastoma cell line:NH-12	10555-107I6	136.60	1.12	0.19	0.00	0.00	15.09	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	109.12	1.90	0.24	0.24	0.00	19.45	2.85
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	126.23	1.27	0.32	0.00	0.16	5.54	4.43
neuroectodermal tumor cell line:TASK1	10774-110F9	168.86	1.61	0.40	0.20	0.40	18.52	2.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	214.89	1.27	0.00	0.64	0.00	17.80	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	129.09	1.33	0.27	0.00	0.27	9.85	2.40
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	177.24	2.54	0.17	0.34	0.34	11.67	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	73.65	3.20	0.00	0.80	0.80	6.40	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	103.24	2.89	0.64	0.00	0.96	4.81	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	111.94	2.63	0.79	0.00	0.26	4.20	1.58
nucleus accumbens, adult, pool1	10037-101F1	90.55	4.31	2.72	2.16	2.06	3.00	7.12
occipital cortex - adult, donor10196	10172-103C1	90.66	6.18	6.18	2.06	0.00	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	100.10	5.64	1.07	1.34	1.61	4.56	4.03
occipital cortex, newborn, donor10223	10355-105E4	80.07	1.82	1.09	0.73	0.36	1.46	2.91
occipital lobe, adult, donor1	10076-102A4	173.45	3.67	3.15	3.94	4.46	9.45	10.23
occipital lobe, fetal, donor1	10073-102A1	174.64	0.86	0.43	0.00	0.00	10.73	18.45
occipital pole, adult, pool1	10036-101E9	68.51	3.31	1.58	2.52	1.73	3.78	5.20
olfactory region, adult	10195-103E6	81.77	4.78	1.34	1.53	1.91	2.10	4.39
optic nerve, donor1	10277-104E7	170.09	2.00	2.00	4.00	2.00	8.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	86.11	0.80	0.00	0.00	0.00	6.49	1.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	124.06	0.69	0.14	0.41	0.00	6.05	3.16
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	198.79	2.03	0.00	0.34	0.51	11.01	3.73
oral squamous cell carcinoma cell line:SAS	10544-107H4	61.34	0.81	0.12	0.35	0.12	5.43	1.39
osteoclastoma cell line:Hs 706.T	10704-109H2	101.42	1.18	0.00	0.29	0.29	7.35	3.53
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	135.48	1.87	0.00	0.00	0.00	12.15	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	77.83	1.27	0.21	0.42	0.42	4.67	0.85
ovary, adult, pool1	10020-101D2	58.44	1.83	0.09	0.35	0.35	2.80	2.53
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	93.31	0.73	0.18	0.00	0.00	8.43	0.55
pancreas, adult, donor1	10049-101G4	89.36	0.94	0.94	0.00	0.00	7.53	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	89.17	3.91	0.56	0.28	0.28	7.27	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	92.84	1.19	0.51	0.00	0.17	3.75	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	82.13	2.98	0.17	0.00	0.00	4.14	1.16
paracentral gyrus, adult, pool1	10035-101E8	93.17	5.31	3.29	3.29	2.75	4.12	4.94
parietal cortex, adult, donor10258	10373-105G4	52.85	0.73	0.73	3.67	1.47	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	67.71	2.82	4.70	0.00	0.00	3.76	4.70
parietal lobe, adult, donor10252	10157-103A4	95.77	8.55	2.00	2.85	2.57	5.13	5.99
parietal lobe, adult, pool1	10034-101E7	94.46	4.93	3.79	3.61	3.17	3.08	5.73
parietal lobe, fetal, donor1	10072-101I9	155.17	0.97	0.00	0.00	0.00	13.58	14.55
parietal lobe, newborn, donor10223	10356-105E5	78.14	2.62	1.50	0.75	1.12	2.24	6.73
parotid gland, adult	10199-103F1	133.20	6.17	0.62	3.08	0.00	7.40	1.85
penis, adult	10200-103F2	75.20	2.15	0.00	0.00	1.07	2.69	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	106.54	0.93	0.19	0.37	0.37	5.39	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	173.23	2.62	0.29	0.73	0.00	8.16	3.35
pineal gland - adult, donor10196	10179-103C8	76.11	0.65	0.65	1.29	0.00	2.58	2.58
pineal gland, adult, donor10252	10160-103A7	108.97	3.55	2.96	2.96	0.59	2.96	4.74
pineal gland, adult, donor10258	10377-105G8	80.89	1.25	0.00	0.63	4.39	3.14	3.76
pituitary gland - adult, donor10196	10180-103C9	55.65	2.02	3.04	0.00	0.00	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	110.49	6.25	3.13	2.61	3.13	2.08	4.69
pituitary gland, adult, donor10258	10378-105G9	89.38	2.55	0.00	0.85	1.70	0.85	4.26
placenta, adult, pool1	10021-101D3	52.35	1.40	0.32	0.00	0.00	3.23	1.94
plasma cell leukemia cell line:ARH-77	10840-111E3	87.80	0.53	0.13	0.26	0.26	7.81	2.25
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	61.79	0.78	0.16	0.16	0.00	4.05	2.18
pons, adult, pool1	10033-101E6	82.71	10.76	3.70	6.20	4.99	4.82	4.65
postcentral gyrus, adult, pool1	10032-101E5	83.60	4.45	3.49	3.14	1.57	2.35	7.32
promyelocytes/myelocytes PMC, donor1	12132-128D8	244.69	2.09	0.00	0.00	0.00	6.27	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00	0.00	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	93.08	2.77	0.58	0.58	0.58	10.20	1.46
prostate cancer cell line:PC-3	10439-106E7	210.36	1.63	0.18	0.73	0.18	12.52	4.17
prostate, adult, pool1	10022-101D4	59.68	2.45	0.18	0.45	0.63	2.45	1.63
putamen, adult, donor10196	10176-103C5	102.69	3.30	1.65	0.47	1.42	1.65	5.90
putamen, adult, donor10252	10152-102I8	117.64	3.92	0.00	0.00	1.96	7.84	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	64.48	0.00	0.00	0.00	0.00	3.28	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	81.66	2.66	1.21	0.24	0.97	0.97	6.28
putamen, newborn, donor10223	10365-105F5	62.97	4.50	1.50	0.00	0.75	3.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	58.19	0.58	0.29	0.29	0.00	7.27	1.16
rectum, fetal, donor1	10067-101I4	168.31	5.56	1.39	1.39	0.00	12.52	9.74
renal cell carcinoma cell line:OS-RC-2	10411-106B6	63.18	0.00	0.42	0.42	0.00	3.82	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	111.42	0.00	0.00	0.41	0.00	4.56	2.90
retina, adult, pool1	10030-101E3	63.22	2.39	0.70	1.09	0.60	2.88	3.38
retinoblastoma cell line:Y79	10475-106I7	146.79	3.38	0.78	2.08	0.78	13.77	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	120.24	0.61	0.25	0.37	0.12	7.87	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	128.79	0.28	0.00	0.00	0.00	16.59	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	82.61	3.03	0.00	0.00	0.00	3.03	2.27
salivary acinar cells, donor1	11771-123I7	50.98	1.29	0.16	0.16	0.16	4.21	1.29
salivary acinar cells, donor2	11772-123I8	47.78	1.24	0.83	0.41	0.00	2.48	1.79
salivary acinar cells, donor3	11773-123I9	30.45	2.65	0.00	0.00	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	145.28	2.86	1.14	0.00	0.57	8.58	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	72.34	0.42	0.00	0.17	0.25	4.05	1.43
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.77	0.24	0.24	0.00	0.00	3.88	2.23
seminal vesicle, adult	10201-103F3	97.35	1.59	0.00	0.53	0.00	3.17	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	55.63	3.64	0.49	1.46	0.73	3.64	3.40
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	56.37	0.75	0.00	0.00	0.00	3.02	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	73.26	0.00	1.00	0.00	0.00	10.04	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	118.34	2.15	0.27	0.13	0.40	9.00	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	106.55	2.21	0.22	0.55	0.22	5.42	1.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	109.54	1.68	0.13	0.00	0.13	13.16	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	195.78	0.71	0.00	0.71	0.71	7.80	4.97
skeletal muscle, adult, pool1	10023-101D5	160.24	4.32	0.24	0.24	0.36	9.83	4.08
skeletal muscle, fetal, donor1	10066-101I3	154.77	0.00	0.00	0.00	1.01	20.10	3.02
skin, adult, donor1	10074-102A2	74.64	0.00	0.00	0.00	0.00	6.79	20.36
skin, fetal, donor1	10065-101I2	99.73	4.42	1.26	0.63	1.89	2.52	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	132.41	3.00	0.00	0.00	0.67	9.67	5.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	91.72	9.14	2.52	0.32	1.26	5.99	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	86.74	0.00	0.00	0.00	0.19	2.12	4.05
small cell lung carcinoma cell line:LK-2	10541-107H1	142.74	6.43	0.16	0.00	0.49	11.87	3.13
small cell lung carcinoma cell line:NCI-H82	10842-111E5	86.22	0.32	0.00	0.00	0.16	6.27	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	56.44	0.44	0.00	0.22	0.22	3.92	0.87
small intestine, adult, pool1	10024-101D6	88.15	2.75	0.12	0.12	0.00	5.73	2.75
small intestine, fetal, donor1	10064-101I1	67.81	2.46	0.74	0.25	0.00	3.19	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	105.14	0.00	0.00	0.51	0.00	4.62	0.51
smooth muscle, adult, pool1	10048-101G3	65.13	3.10	0.00	0.26	0.26	2.58	2.58
somatostatinoma cell line:QGP-1	10781-110G7	99.44	0.27	0.00	0.00	0.00	7.50	1.61
spinal cord - adult, donor10196	10181-103D1	134.20	6.42	1.38	0.92	1.61	5.51	4.82
spinal cord, adult, donor10252	10159-103A6	84.37	13.01	1.18	0.39	2.37	3.15	2.76
spinal cord, adult, donor10258	10369-105F9	56.04	4.84	1.38	2.08	5.53	2.77	1.38
spinal cord, fetal, donor1	10056-101H2	140.26	2.44	1.22	1.22	0.00	8.54	5.49
spinal cord, newborn, donor10223	10359-105E8	79.44	7.35	3.21	0.92	2.30	2.76	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	115.15	1.19	0.30	0.45	0.60	11.50	2.69
spleen, adult, pool1	10025-101D7	70.82	2.09	0.22	0.11	0.11	4.30	1.32
spleen, fetal, pool1	10044-101F8	64.20	1.43	0.00	0.00	0.08	3.65	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	103.10	1.45	0.72	0.31	0.83	8.28	1.86
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	91.52	0.76	0.00	0.00	0.19	5.70	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	69.89	1.05	0.00	0.00	0.00	3.84	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	66.46	0.00	0.00	0.00	0.00	3.91	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	312.24	2.93	0.79	0.45	0.34	17.78	4.50
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	135.98	0.00	0.00	0.00	0.00	4.66	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	154.42	0.42	0.85	0.00	0.00	8.46	1.69
stomach, fetal, donor1	10062-101H8	145.24	7.48	1.07	0.00	2.14	1.07	1.07
submaxillary gland, adult	10202-103F4	135.58	4.56	0.57	0.57	0.00	8.55	3.42
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	92.22	8.10	2.08	0.83	1.25	3.53	1.25
substantia nigra, adult, donor10258	10371-105G2	73.97	5.69	0.00	0.52	3.10	0.52	3.10
substantia nigra, newborn, donor10223	10358-105E7	89.74	1.41	1.41	0.71	0.71	4.95	4.24
synovial sarcoma cell line:HS-SY-II	10441-106E9	122.20	2.29	0.46	0.00	0.46	8.71	4.81
temporal lobe, adult, pool1	10031-101E4	79.85	3.73	1.95	1.10	2.37	3.65	5.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	108.98	1.42	0.71	1.42	0.00	12.11	12.11
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	95.38	1.76	0.00	0.00	0.00	3.52	8.35
tenocyte, donor1	11763-123H8	50.97	4.19	0.70	0.70	0.00	4.54	1.05
tenocyte, donor2	11765-123I1	48.45	2.29	0.00	0.00	0.38	3.43	1.53
tenocyte, donor3	11768-123I4	67.83	3.34	0.74	0.37	0.74	4.45	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	176.08	2.04	0.34	0.00	0.00	25.66	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	77.84	1.54	0.46	0.00	0.00	8.32	0.62
teratocarcinoma cell line:PA-1	10807-111A6	145.21	0.15	0.00	0.00	0.00	17.67	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	163.64	4.19	0.00	0.00	0.00	18.66	1.52
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	105.51	1.51	0.38	0.00	0.00	8.32	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	89.32	4.69	0.00	0.00	0.00	17.23	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	149.17	1.30	0.33	0.00	0.00	17.26	1.95
testis, adult, pool1	10026-101D8	81.07	2.68	0.32	0.21	0.11	2.79	3.65
testis, adult, pool2	10096-102C6	98.34	0.45	0.00	0.45	1.35	3.61	3.16
thalamus - adult, donor10196	10168-103B6	105.98	2.21	1.10	0.00	2.21	1.10	4.42
thalamus, adult, donor10252	10154-103A1	98.15	8.91	2.81	1.09	1.41	4.22	3.44
thalamus, adult, donor10258, tech_rep1	10370-105G1	64.66	1.54	1.54	1.54	0.00	4.62	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	120.55	3.29	1.32	1.65	1.48	6.92	6.09
thalamus, newborn, donor10223	10366-105F6	88.60	6.33	1.15	0.00	0.00	1.15	3.45
throat, adult	10209-103G2	99.37	3.50	0.25	0.50	0.50	3.25	3.00
throat, fetal, donor1	10061-101H7	123.10	3.35	0.91	2.74	0.91	7.62	4.27
thymic carcinoma cell line:Ty-82	10803-111A2	164.55	2.58	0.99	0.60	0.20	12.32	5.17
thymus, adult, pool1	10027-101D9	155.98	2.58	0.30	0.70	0.40	21.47	1.59
thymus, fetal, pool1	10043-101F7	117.72	2.49	0.52	0.52	0.21	15.59	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	56.91	0.80	0.00	0.13	0.40	3.86	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	69.85	1.26	0.42	0.28	0.14	6.43	0.98
thyroid, adult, pool1	10028-101E1	74.74	2.61	0.65	0.75	0.75	3.45	3.45
thyroid, fetal, donor1	10060-101H6	109.95	1.05	0.26	0.79	0.00	4.75	5.27
tongue epidermis (fungiform papillae), donor1	10288-104F9	132.42	6.16	0.00	0.00	0.00	6.16	0.00
tongue, adult	10203-103F5	109.54	4.42	1.40	0.70	0.70	7.44	2.33
tongue, fetal, donor1	10059-101H5	119.80	5.91	1.97	0.39	0.00	5.12	3.94
tonsil, adult, pool1	10047-101G2	85.75	1.70	0.30	0.40	0.30	2.91	2.00
trachea, adult, pool1	10029-101E2	66.09	2.29	0.25	0.41	0.16	2.86	1.64
trachea, fetal, donor1	10058-101H4	92.33	4.62	0.38	1.15	0.77	4.23	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	125.06	1.77	0.00	0.00	0.00	7.79	2.83
transitional-cell carcinoma cell line:5637	10418-106C4	77.10	2.13	0.30	0.00	0.20	5.07	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	180.97	2.04	0.16	0.31	0.16	15.04	7.05
tridermal teratoma cell line:HGRT	10694-109G1	114.15	3.81	0.00	0.00	0.00	5.71	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	86.43	1.35	0.08	0.00	0.08	6.69	1.95
umbilical cord, fetal, donor1	10057-101H3	64.68	4.17	0.00	0.00	0.00	8.35	2.09
uterus, adult, pool1	10100-102D1	73.37	2.22	0.00	0.34	0.17	2.22	2.22
uterus, fetal, donor1	10055-101H1	90.61	3.07	0.00	0.00	0.00	6.66	4.61
vagina, adult	10204-103F6	37.48	3.23	0.00	0.00	0.00	1.94	1.29
vein, adult	10191-103E2	80.88	1.32	0.22	0.44	0.22	5.48	2.63
xeroderma pigentosum b cell line:XPL 17	10563-108A5	60.62	0.80	0.27	0.27	0.53	2.14	0.53